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Executive Summary 
 
Despite widespread use, the majority of indicators proposed as measures of the quality of maternal 
health services have not been sufficiently validated. To help accurately track progress towards national 
and global maternal health goals, the present study sought to validate and identify a set of maternal 
health indicators that can be practically applied in facility and population-based surveys. To evaluate the 
indicators, the study employed a facility-based design. The study was conducted in public /government 
hospital facilities in Kenya and Mexico. Participants included women aged 15-49 who underwent labor 
and delivery at participating study facilities and the providers who attended them. Women’s self-report 
of obstetric and immediate postnatal maternal and newborn care received was compared against a 
“gold standard” of observations by a trained third party observer during labor and delivery.  
 
This report presents results of the Mexico study. Data collection took place between November 2013 
and April 2014. A total of 600 births were observed and the mothers participated in an exit interview 
prior to hospital discharge. A large proportion of assessed indicators were either routinely practiced or 
rarely occurred. The lack of variation in observed interventions limited the ability to conduct full validity 
analysis for some indicators. Of the 108 indicators assessed, 48 had sufficient variation for validity 
analysis using area under the receiver operator characteristic curve (AUC) and inflation factor (IF) 
analysis.  
 
Of assessed indicators, 5 met both acceptability criteria for both AUC (AUC>0.6) and IF (0.75<IF<1.25). 
These were: whether a urine sample was taken upon hospital admission, whether an injection or IV 
medication was received at some time during labor (before the birth of the baby), episiotomy, 
hemorrhage, and receipt of blood products. Findings suggest events that caused pain, concern or were 
considered ‘important information’ by mothers, were particularly salient for women and may have 
enhanced recall. Important to note is that although a urine screening test, hemorrhage and receipt of 
blood products each met both validity criteria, these indicators had moderate or low sensitivity (50% or 
lower). As the lower sensitivity and specificity for these indicators balances out at the aggregate level, 
these indicators may be more appropriately applied to estimate the population-based coverage of these 
events.  Also of note is that while an indicator of whether an injection of IV medication was received at 
some time during labor met both validity criteria, additional findings indicate that women are unable to 
report on the indication for the medication (if received for induction or augmentation of labor). Taken 
together, these indicators are recommended dependent on the objective of their use (i.e., for accurately 
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classifying ‘true positive’ and ‘negative’ cases or for obtaining an approximate population-based 
prevalence).  
 
A total 28 indicators met acceptability criteria for one of the validity measures; 19 indicators met the IF 
criteria and 9 met the AUC criteria only. While having high sensitivity and specificity for indicators is 
important in ascertaining which women received care at an individual level, approximating the broader 
population-based prevalence can also provide actionable data on the coverage of maternal and 
newborn health care received. For example, in some cases, underreporting of true cases and false 
positive reporting of negative cases (i.e., low indicator sensitivity and specificity) equaled out to 
generate acceptable estimates for monitoring coverage at the population level. We recommend caution 
with regard to low-prevalence indicators that, without near-perfect specificity (i.e., true negative 
classification), are likely to be overestimated. 
 
Of key objective of the present study was to validate the skilled birth attendance indicator. Attendance 
by a skilled provider (defined as any doctor- specialized or a general practitioner, medical resident or 
nurse) was near universal and unable to be robustly analyzed. Cross-tabulation results, however, 
indicate that the majority of women observed to have skilled birth attendance, correctly reported 
receiving skilled care (high sensitivity). We also assessed if women could accurately ascertain what 
category of provider was responsible for the majority of care. We found a combined doctor (any type) 
and medical resident indicator could be reported with accuracy at the population-level, but was not 
suitable for individual-level classification given the tendency for overreporting by women. Given the little 
distinction between skilled doctor categories however, the inability of women to distinguish between 
finer distinctions of providers may be less programmatically meaningful than the ability to report on the 
coverage of the indicator at the aggregate level.  
 
Although it was not possible to validate indicators with near universal practice, descriptive cross-
tabulation results suggest that women may be able to report on some aspects of routine care with 
accuracy. For example, women reported on their newborn’s birthweight with near perfect classification, 
although so few women incorrectly reported their newborn birthweight that robust analysis was not 
possible. An additional indicator of potential high use not able to be assessed in the present study was 
the type of facility where women delivered. Although the present study was not designed to evaluate 
this indicator, descriptive results suggest a high proportion (85%) of women correctly identified the type 
of institution where they delivered. Results also suggest that the two-part question methodology to 
identify institution type, also used in DHS and MICS surveys, is important. These indicators should be 
explored further in studies with multiple facility types (private and public sector), or different practices 
for recording newborn weight.  
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In sum, study findings suggest women in a facility-based setting validly report 5 indicators of maternal 
health services and immediate newborn care. An additional 19 indicators met the IF criteria only and 9 
met AUC criteria only. We recommend the use of these indicators with caution and dependent on 
whether the purpose is to identify coverage at the population level, or to distinguish among true positive 
and negative cases at an individual level. Results suggest indicators related to timing, technical 
terminology, and the sequence of events may be reported with difficulty. Taken together, findings 
suggest the validity of a number of indicators may be highly dependent on context and question 
wording.  Future studies should explore how key terms and questions related to timing and order of 
events are understood by women in order to enhance indicator accuracy.  
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Study Background 
 
Global monitoring of the percentage of women who have received quality maternal health services is 
crucial to guide the scale-up and allocation of resources to reduce preventable maternal deaths. Given 
difficulties in measuring maternal deaths, the proportion of births attended by skilled health personnel 
and the proportion of births delivered in health facilities have become widely used indicators to 
measure progress towards maternal health goals. Coverage rates of ‘skilled attendance’ and 
‘institutional deliveries’ have become benchmarks for quality of maternal health care routinely tracked 
by national and international agencies. 
 
Reliance on these indicators requires the assumption that women delivering in an institution with the 
assistance of a skilled attendant will also have access to essential services, such as emergency 
obstetric care and lifesaving commodities including uterotonics, magnesium sulfate, and antibiotics.1,2 
Given discrepancies in the quality of care between providers and facilities, however, identifying the 
actual interventions that a woman receives is necessary to provide a more accurate assessment of the 
coverage of key interventions.  
 
Little previous research has been conducted on this topic. To our knowledge, the two most widely used 
proxy indicators – skilled attendance at birth and institutional delivery – have not been empirically 
validated or systematically evaluated. In addition, there have been few attempts to test the feasibility of 
collecting data on specific elements of the care received by women during labor and delivery.3-7  
 
In response to a call to increase reliable maternal health information in the Lancet “Manifesto for 
Maternal Health”, a 2013 PLOS Medicine special issue reported in partnership with the Child Health 
Epidemiology Reference Group (CHERG), includes three quantitative studies in this area. These studies 
examine the validity of women’s reports of: 1) the indications for cesarean sections in Ghana and the 
Dominican Republic8, 2) indicators of care received by women and their newborns during labor, delivery, 
and the postnatal period in Mozambique,9 and (3) indicators of care received by women and newborns 
in rural China.10 In these studies, women’s reporting of events during labor and delivery is compared 
against a reference standard, either medical records or observation in a health facility. In addition, a few 
small qualitative studies have examined whether specific events during labor and delivery (e.g., cord 
cutting) were understood and recalled by women, whether women were able to recall their sequence 
and timing, and the terms used to describe them.11-13  
10 
 
The present study extends previous research by comparing women’s self-reports of maternal and 
newborn service provision during the intrapartum and early postnatal periods prior to discharge from a 
hospital facility to third party observation at the time of delivery. The study also provides insight into 
factors (e.g., participant variables, type of delivery, instances of complications or other events) that may 
influence the accuracy of recall. The results of the study inform the recommendation of a select number 
of indicators that have the potential for valid and reliable measurement and for integration into routine 
population-based and facility-based data collection systems. 
 
Mexico and Kenya were chosen as study sites in light of variations in the status of maternal health and 
the coverage and organization of maternal health services. This report presents results from the Mexico 
study.  
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Study Overview 
OBJECTIVE 
 
The goal of the study is to improve monitoring of the quality of maternal health care through identifying, 
developing, and validating maternal health indicators that can be practically applied in population-
based surveys. The main question addressed by this research is: Can accurate information on the 
quality and content of maternal health care received by women during labor and delivery be self-
reported by women in a survey format? The two specific objectives of the study are: 
 
1. To assess the validity of women’s reports of skilled birth attendance; and 
2. To assess the validity of women’s reports of indicators of the quality of routine obstetric and 
immediate postnatal service delivery. 
 
INDICATOR SELECTION  
 
To identify quality care indicators for maternal health to be validated, a landscaping scan was 
conducted from April to July 2012. The scan focused on indicators currently in use or proposed for use, 
including both population-based and facility-based indicators. Indicators were identified by performing a 
key word search of electronic databases, including: PUBMED, POPLINE, JSTOR and EMBASE. We 
conducted additional searches of publications from organizations known for their involvement in 
measuring maternal health care, such as WHO, UNICEF, UNFPA, MCHIP, AMDD and IMMPACT, and by 
searching reference lists of identified papers and reports. Key search terms included maternal health, 
safe motherhood, quality of care, indicator, valid, skilled attendant, neonatal, perinatal, obstetric, and 
intrapartum. No studies were excluded on the basis of language or date of publication.  
 
An indicator matrix was developed to organize findings. From an identified 2,505 documents, 71 
provided information on indicators for assessing quality in maternal healthcare. This listing was used to 
select indicators for validity testing (see Annex A, Table 1). These indicators were considered the most 
commonly used or critical variables for assessing the quality and coverage of maternal care. The 
observation and interview questionnaires were translated into the appropriate local dialects and 
underwent minor modifications to improve local understanding and clarity for participants. 
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STUDY DESIGN 
 
To accomplish the stated objectives, the validation study employs a facility-based design with 
comparisons against a gold standard. Specifically, women’s reports on indicators of the quality of 
maternal health care they received are compared against third party observations of the care provided 
at the time of labor and delivery using a structured checklist.  
 
Third party observations were chosen as the reference standard since they are likely to reflect all facets 
of the care-giving process. In the event that additional information or clarification was needed, medical 
and facility records were also checked. Women’s self-reports of the services they received at the time of 
labor and delivery were gathered via exit interviews prior to their discharge from the participating 
hospital facility, Hospital General de México “Dr. Eduardo Liceaga”, Mexico City, Mexico.  
 
 
ETHICAL CLEARANCE 
 
The protocol was approved by the Population Council’s Institutional Review Board in May 2013 (IRB 
Protocol 594) and by the Ethics and Research Committees of the Hospital General de México “Dr. 
Eduardo Liceaga” in October 2013. No participants were enrolled in the study until ethical approval was 
obtained from both ethics committees. 
 
Ethics and Research Committees Research Division  
Hospital General de México “Dr. Eduardo Liceaga” 
Dr. Balmis 148 
Colonia Doctores 
Mexico City, 06726 
Mexico 
Tel. +52 55 2789200 ext. 1164 
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Methods 
RESEARCH SITE & STUDY POPULATION 
 
Study Population:  
 
The study population consisted of women whose births were documented by study data collectors at the 
participating study facility between November 2013 and April 2014. Women aged 15-49 who were 
admitted for labor at the study facility and who consented to study participation were eligible for 
inclusion. The study population also included the providers who attended participating women in labor 
and delivery and whose labor and delivery care was observed by study data collectors.  
 
Study Location:  Hospital General de México Dr. Eduardo Liceaga (HGM), Mexico City 
 
All women were recruited from the above hospital, a public facility in Mexico City. HGM provides 
comprehensive obstetric care to women with normal pregnancies who are self-referred for admission, in 
combination with high-risk pregnancies that are referred from other public primary or secondary health 
care institutions. The hospital population in Mexico City tends to have a lower-than-average 
socioeconomic status and characteristically lacks health insurance. Patients may travel large distances 
to HGM. Slightly more than half of the patients who receive health care at HGM live in Mexico City, with 
a significant proportion from the neighboring State of Mexico (37%) and 5% from the rest of the 
country.14  
 
On average in Mexico, hospital-based deliveries are proportionately high. Data from the most recent 
national health survey indicate that 94% of women delivered with a medical doctor.15 HGM is one of the 
public hospitals in Mexico City with the highest volume of obstetric patients and in 2013 provided 
delivery care for 4169 women, of which 2235 (54%) were vaginal births.  
 
RECRUITMENT PROCEDURES 
 
Data Collectors 
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Two types of data collectors were involved in this study: observers, who registered the quality and 
content of obstetric care provision; and interviewers, who applied questionnaires to women prior to 
hospital discharge. Observers were general medical practitioners or nurses with sufficient clinical 
training to accurately observe delivery room practices and procedures and to know how to conduct 
themselves professionally. Interviewers were social workers and psychologists with qualitative research 
experience. We recruited only female interviewers in order to facilitate rapport with participating women. 
All data collectors were external to HGM and not personally known to hospital staff in order to minimize 
observer bias and to ensure respondents’ anonymity. In addition, we selected a study coordinator from 
the pool of observer applicants.  The study coordinator had previous research and managerial 
experience and provided supervision and support to fieldwork teams. 
 
Job openings for data collectors were posted on university websites and list serves. Interested 
applicants who fulfilled our criteria were interviewed and asked for professional references. Most of our 
observers held part-time jobs elsewhere or were studying for admission into medical residency 
programs. Their shifts were thus scheduled around their availability to give them flexibility to continue 
with those activities.   
 
 
Data Collector Training 
 
Data collection training for observers and interviewers took place over two consecutive days in October 
2013. Training included detailed study protocol description, practice using data collection instruments, 
and key ethical aspects of research, stressing the importance of informed consent. Sessions included 
teaching tools such as role-playing dynamics and question-and-answer sessions to clarify technical 
concepts. All field staff were required to complete and submit a certificate of the NIH online training 
course “Protecting Human Research Participants” (https://phrp.nihtraining.com/users/login.php) to 
ensure that they fully understood and adhered to human subject research ethics. Training manuals 
were developed and distributed to all data collectors, who were instructed to use them as a reference 
during study implementation.  
 
Study interviewers were trained to listen and observe intently, without displaying judgmental attitudes 
towards information they received. They were instructed to read out questions as worded in the 
questionnaires and to offer additional explanations only when strictly necessary. Observers received 
training on procedures for being unobtrusive and for locating themselves toward the head of the client 
rather than the foot when possible. Observers also received information on how to conduct themselves 
in the event that they witnessed unacceptable provider behavior that put clients at risk of morbidity and 
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how and when to intervene. Both interviewers and observers were instructed to keep all data collection 
instruments in strict confidentiality. 
 
Because all but two of our observers and our study coordinator took new jobs or began their medical 
residencies in January 2014, we conducted new recruitment and training to replace these staff. The 
second training was a one-day workshop that covered the same content as the original training. 
Contrary to what occurred with the observers, the interviewer group remained throughout the study 
period. Although no refresher trainings were conducted as a group, our study coordinators gave 
constant feedback to observers and interviewers and were available to respond to their questions and 
solve problems as they arose. 
 
 
Process for Participant Recruitment and Informed Consent 
 
All women who were undergoing labor and delivery at HGM and met the inclusion criteria were eligible 
for study participation. Inclusion criteria were: 1) women aged 15-49 years old (the same age range as 
in the DHS), 2) admitted for delivery at HGM and able to provide consent, and 3) the health care 
providers who attended the woman in labor and delivery. Women were excluded if they were unable to 
provide consent (including unconsciousness or presenting with a complication) or if their stage of labor 
was considered too advanced by the attending medical personnel. Women were eliminated from the 
study if a cesarean section was indicated at any point during labor.  
 
When women were admitted to the labor ward, health providers asked them whether they were willing 
to meet with a member of the research team. If the woman gave her permission to speak with an 
observer, the health provider identified an appropriate time (relative to her clinical status) to meet with 
her. The observer then explained the study procedures, including the fact that a researcher would stand 
in the corner of the room during her labor and delivery and use a checklist to record the actions of the 
doctors or nurses.   
 
Written informed consent was then obtained from interested participants and, in accordance with local 
ethical guidelines, consent was also requested from their spouses/common law partner or parents 
when applicable. For participants who were minors, information about the study was also provided to, 
and written consent sought from, their parent or spouse/ common law partner (as responsible parties). 
Everyone who participated in the informed consent process was given a copy of the consent form with 
the study information and signature page. The main informed consent process included both study 
16 
activities: observation and exit interview. Before each data collection activity, study interviewers 
confirmed that women still wished to participate and requested their verbal consent.  
 
Provider consent was obtained to observe health care workers in the labor and delivery ward. Before 
study implementation began, several meetings were organized by the OB-GYN director for our research 
team to explain the study to nurses and doctors, answer their questions, and obtain their informed 
consent. Once the study began, the study coordinator and observer team individually approached 
providers who had not attended the larger staff meetings to obtain their consent. This was especially 
important since new hospital personnel were constantly recruited.  
 
A list of providers who gave their consent was available for observers to check against before their 
observations. Consultations were observed only if provider consent had been obtained. Very few 
providers did not agree to participate in the study and, in those cases, we did not conduct observations 
of the services they provided.  
 
 
Data Collection Procedures 
 
Data collection was carried out from 1 November 2013 to 23 April 2014.  Data were collected 
continuously, seven days per week, 24 hours per day. There were 3 shifts for staff carrying out 
observations, with two data collectors per shift. On average, observers worked 3 to 4 shifts per week, 
while interviewers worked individually and were assigned an average of two shifts per week. Interviewer 
shifts (10 am to 5 pm) were designed to cover the period when patients were discharged from the 
hospital. Data collection was briefly interrupted at the beginning of February, as our first group of 
observers left the study and we trained a new team. Data collection was also suspended during national 
holidays. 
 
With the objective of gaining better insight into data quality, we conducted debriefing sessions with the 
fieldwork teams two weeks after concluding data collection. We carried out two separate group 
interviews: one per observer and interviewer teams. The information collected was used to interpret our 
quantitative findings. 
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Results 
STUDY SAMPLE 
 
A total of 779 women admitted for labor at Hospital 
General were recruited to participate. Because of 
hospital policies that allowed the complete observation 
only of women who underwent vaginal deliveries, data 
collection for women who became indicated for 
cesarean sections was discontinued at the time of 
indication. Figure 1 depicts a flow chart of data 
collection for women who could be observed throughout 
their labor and delivery (i.e., women who delivered by 
vaginal birth). Specifically, 616 women who consented 
to participate in the study delivered by vaginal birth. Of these women, 609 (99%) were successfully 
observed during labor and delivery. A total of 7 (1%) women were not observed as a result of being sent 
home because they did not progress into labor, because they could not be located after recruitment, or 
because they requested to be discharged from the hospital prior to delivery. Of the women whose labor 
and delivery was observed, 600 completed an exit interview prior to hospital discharge. Exit interviews 
were not completed for 9 women (2%) who either refused participation at the time of interview or 
because they received an early hospital release. 600 observer reports and client exit interviews were 
accurately matched and could be analyzed. In the following sections, all data refer to women who 
delivered by vaginal birth only, unless otherwise specified. 
 
SAMPLE DESCRIPTIVES 
Descriptive statistics on the sample’s socio-demographic and delivery characteristics are presented in 
Table 1. The mean age of women was 24 years (Std. Dev. ±6) and ranged between 15 and 42 years. 
The majority of women (56%) were living with a partner (en unión libre) or were currently married (18%), 
whereas one-quarter were single and had never been married (26%). Approximately half of women had 
given birth previously (52%). Of women who had previously delivered, most of the women had one prior 
birth. The highest parity among women was seven prior births. Nearly all of the women reported 
secondary school education or higher as their highest level of completed education (92%). Of these 
women, approximately 40% had completed or obtained at least some post-secondary education (42%) 
Completed exit 
interview. 
N = 600; Follow-up 
Rate: 98.5% 
Hospital General de Mexico 
 
Consented to study 
participation (vaginal delivery 
only) 
N = 616 
 600 women with matched 
data. 
Could not be located 
or left the hospital. 
N = 7; Loss to FU 
Rate: 1.2% 
Successfully observed 
during labor & delivery. 
N = 609; Observation 
Rate: 98.8% 
Lost to follow-up or 
refused survey. 
N = 9; Loss to FU 
Rate: 1.5% 
Figure 1. Participant response rates (vaginal 
                 delivery), Mexico. 
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or tertiary/ preparatory school (41%), and less than 10% had completed or obtained at least some 
education at the university or graduate level (8%). Of observed vaginal deliveries, 3% were assisted with 
forceps.  
 
Study participants who became indicated for cesarean operation after study enrollment (and for which 
observation was discontinued at the time of indication) did not differ from all other women on key 
sociodemographic characteristics such as age, marital status, or education level. Women who 
underwent a cesarean operation had, on average, fewer previous births than women who delivered 
vaginally (mean difference: 0.3± Margin of Error 0.1, p<0.001).  
 
 
Maternal and Newborn Outcomes 
 
A total of 604 deliveries were observed, including 2 
sets of twins. Less than 1% of births resulted in a 
stillbirth (n=2) or neonatal death (n=1) (i.e., newborn 
died within the first hour of delivery).  
 
The majority of participants reported coming to the 
facility because they had planned to deliver there 
(72%), while 28% reported coming because they had 
a problem, such as needing to be referred to an 
alternate facility for medical care or an inability to pay. 
Complications were observed among 14% of women. 
Most complications were observed following delivery 
(44%), while approximately 40% occurred during 
delivery (38%), and 19% occurred prior to delivery. 
The most common type of complication was 
hemorrhage (APH+PPH) (8% of women), followed by 
eclampsia (2%), and prolonged labor (>12 hours), (2% 
of women). Less than 1% of women with 
complications experienced more than one.  
 
Service Delivery Coverage 
 
The indicators selected for validity testing are presented in Annex A, Table 1. The table describes the 
matched prevalence of each indicator by women’s self-report (‘reported’ prevalence) and observer 
TABLE 1.  Sample background characteristics*. 
Age  Percentage (%)  
  15-19 27.2  
  20-24 36.3  
  25-29 19.2  
  30-34 9.7  
  35-39 5.9  
  40+ 1.6  
Prior parity ( total # live births)  
  0 47.7  
  1 29.4  
  2 14.7  
  3 5.6  
  4 or more 2.6  
Educational level  
  None 0.2  
  Primary 8.4  
  Secondary 42.3  
  Higher 49.2  
Marital status  
  Single, never married 25.5  
  Married 17.8  
  Living together 55.7  
  Separated 1.0  
  Widowed 0.0  
Type of vaginal delivery  
  Unassisted 97.5  
  Assisted forceps 2.5  
Note: *Data refer only to women who delivered vaginally.  
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report (‘true’ prevalence), excluding “Don’t Know” responses. The observed prevalence of indicators 
ranged from extremely rare (<5%) to near universal (>95%). The broad range indicates that some 
preventive interventions were almost always implemented, while other harmful practices rarely 
occurred. Indicators meeting these criteria are listed in Annex A, Table 2. 
 
A total of 18 indicators had an observed prevalence >95%, while 13 indicators had an observed 
prevalence <5%. Universal or rare practices reflected standard hospital practices or policies. For 
example, it was the standard practice for newborns to be wrapped in a towel and then placed with the 
mother, rather than being placed directly naked against the mother’s chest (skin-to-skin) and then 
covered with a towel or cloth. Other standard practices were that women were generally not allowed to 
eat or drink during labor or to have a support companion present during labor or delivery.  
 
Of note is that few HIV tests were offered (2%). This was in part because few HIV tests were available at 
the facility, and because the practice of first checking the woman’s HIV status by either asking the 
woman or consulting her records was high (70%) (n=169). Similarly, few women were observed to 
receive HIV testing (1%).  A greater proportion of women who were offered HIV testing were observed to 
receive the test (3 of 10 women; 30%). Provider hand-washing practices were also notably low. In 
contrast to the low level of observed hand-washing, there was a near universal practice of providers 
wearing high-level disinfected or sterile gloves during examinations of the woman.   
 
For all indicators, women and observers were given the option to respond, “Don’t Know”. The proportion 
of women who responded “Don’t Know” to indicators was minimal (<5%). Indicators where the 
proportion of women who responded “Don’t Know” exceeded 5% are reported in Annex A, Table 3.  
 
The greatest proportion of women responded “Don’t’ Know” to the indicator, “Did anyone give you a 
medication called ‘oxytocin’ to make your womb contract or become firm?” (37% “Don’t Know”). 
Potential explanations for this high percentage are that women were not informed if they were given 
oxytocin or that women did not know what the drug was for and its name was not salient. Other 
practices with a high self-reported “Don’t Know” prevalence were also related to indicators of care 
received in the immediate postnatal period. This included the oxytocin indicator, as well as whether a 
uterotonic for the prevention of postpartum hemorrhage (PPH) was received following delivery– whether 
in the first few minutes after delivery, “anyone [gave] medication intravenously through a tube in your 
arm” (7% “Don’t Know”). At the same time, observer reports indicate that nearly all women received the 
prophylactic uterotonic oxytocin following delivery, and that it was administered via an IV line in the arm. 
Taken together, these descriptive findings suggest that many women have difficulty reporting on 
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indicators related to receiving a uterotonic for the prevention of postpartum hemorrhage. High “Don’t 
Know” responses were also given for other postnatal practices related to immediate newborn care and 
postnatal health checks. 
 
The percentage of women who were able to report on whether anyone offered them an HIV test was 
also notably low (23% “Don’t Know”). Study data collectors noted that many women did not know what 
HIV was, or confused it with human papillomavirus (HPV), which may account for the high “Don’t Know” 
percentage. Indicators on whether the provider washed his or her hands before examining her or 
whether the newborn was given anything to drink besides breastmilk in the first hour after delivery may 
reflect uncertainty due to the practice occurring outside of the woman’s view.  
 
Observer responses of “Don’t Know” were also minimal across indicators and, where they occurred, 
were generally less than 2% of responses (Annex A, Table 3). Six indicators had an observer report of 
“Don’t Know” of 3% or greater. These indicators generally related to practices that may have occurred 
outside of the labor and delivery room, such as whether the baby was given anything other than 
breastmilk to eat within the first hour after birth (6% “Don’t Know”), whether the provider checked the 
woman’s HIV status, or whether the provider washed his or her hands before examining the woman (4% 
and 3% “Don’t Know”).  
 
VALIDITY OF QUALITY OF CARE INDICATORS 
 
 
Analytic Approach 
 
The general approach for the validity analysis relied on comparing women’s self-report of each quality of 
care indicator to its “true” classification according to the observer report (i.e., reference standard) at the 
time of facility-based delivery. Using these data, sensitivity and specificity for each indicator were 
calculated using two-by-two tables. An indicator’s sensitivity is the proportion of actual positives (women 
who received care) that were correctly identified as such (i.e., “true positive rate”). An indicator’s 
specificity is the proportion of negatives (women who did not receive care) that were correctly identified 
as such (i.e., “true negative rate”). For indicators meeting the criteria of at least 5 counts per cell, we 
also calculated the area under the receiver operating curve (AUC) and the inflation factor (IF).   
 
Receiver operating curve analysis is a valuable method to describe the accuracy of diagnostic tools by 
plotting the tradeoff between sensitivity (true positive rate) against its false positive rate (or 1- 
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specificity). In practice, the area under the curve (AUC) represents the “average accuracy of a diagnostic 
test” and summarizes the test’s sensitivity and specificity by a single number.16-18 An AUC of 1.0 can be 
interpreted as a test with perfect accuracy, while an AUC of 0.5 represents a random guess.19 To assess 
the population-based validity of indicators, we also estimated each indicator’s inflation factor (IF). Using 
an equation by Vecchio, each indicator’s estimated sensitivity, specificity is applied to its true 
prevalence (or observer report) to estimate the prevalence of an indicator that would be obtained using 
a population-based survey.20 By comparing the ratio of the estimated survey-based prevalence to its 
true population prevalence (observer report or ‘reference standard’), we estimate the degree to which 
each indicator would be over- or under-estimated if assessed using a population-based survey.21 
 
A priori benchmark criteria for ‘valid’ indicators were an AUC>0.6 and an IF between <1.25 and >0.75 
and were informed by criteria previously used in the literature.9,10  Use of the two methods provides 
complementary data to inform indicator use in population-based surveys. Indicators with sufficient 
variation to allow for validity analysis are 
presented in Annex B. For indicators listed in the 
text, prevalence data refer to matched indicator 
data. In the results section that follows, the AUC 
and its margin of error are also reported.  
 
Facility Arrival & Initial Assessment  
 
Type of facility 
 
Of interest is whether women can accurately 
report on the type of facility where they delivered. 
Replicating the methodology of DHS and MICS 
surveys, women were asked to identify where they 
gave birth by first indicating whether they 
delivered in a public or private sector institution. 
Women were then asked to specify the facility 
type as a hospital, health clinic/center, health 
post, or other location. If women were unable to 
determine whether the facility was public or 
private, they were asked to name the facility. Since the participating study facility was a 
public/government hospital (100% true or ‘observed’ prevalence), the present study was not designed 
Box 1A. Descriptive frequencies: Type of facility. 
Can you tell me the type of facility where you gave birth to your 
baby? (Self’-report) 
        Number Percent 
Public Sector   
Govt. hospital                         380 85.2 
Govt. clinic/health center   7 1.6 
Govt. health dispensary             0 0 
Other public sector 11 2.5 
   Private Sector   
             Private hospital      45 10.1 
               Private clinic       3 0.7 
Private maternity home 0 0 
Other private sector 0 0 
               Total Reported in Categories               446 100 
Box 1B: Woman not able to determine whether private or public 
but specified facility details. 
 Number Percent 
Facility name (Hospital General de 
Mexico) 120 83.3 
Hospital and public/ govt. type 5 3.5 
Hospital (other) 13 9.0 
Other facility detail (location, level, etc.) 6 4.2 
Total Specified 144 100 
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to assess whether women can accurately report on this indicator. However, cross-tabulation results 
show that of women who classified the facility as public or private sector and then specified the level of 
facility, 85% of women correctly classified the type of facility as a public hospital (Boxes 1A-B).  
 
24% of women (n=144) were not able to classify Hospital General as a private or public sector facility 
but did specify the facility name or other details. 83% of these women correctly specified the facility 
name as “Hospital General” or “Hospital General de México”. An additional 9% of women who could not 
identify the type of facility were able to report it was a hospital of some kind (but not a public sector or 
governmental hospital). Notably, 4% of women were able to report the facility was a hospital and part of 
the public or government sector (e.g., by reporting “Hospital público”, “Hospital federal”, or “Hospital de 
asistencia pública”). The fact that women could identify the facility as a government or public sector 
hospital by being asked to report the facility name in an open-ended question but were not able to 
classify the facility using pre-existing categories suggests that more women are able to accurately report 
on the facility type than are captured in initial questioning. Some women (4%) also provided additional 
correct details about the facility, such as its level, location, or ability to offer specialized care, but not 
whether the facility was in the public sector or a hospital. 
 
 TYPE OF FACILITY: SUMMARY 
Descriptive results suggest that both parts of the DHS and MICS indicator question methodology – 
categorical responses and specific facility names - are important in capturing self-reported information 
on the type of facility. These results should be interpreted with care as they are descriptive only. 
 
Initial assessment practices 
 
Two indicators of the initial client assessment 
phase could be assessed. Other practices were 
near universal or rarely occurred and did not 
meet criteria for robust analysis.  Assessed 
indicators in the initial client assessment phase 
were: (1) whether the woman’s HIV status was 
checked and (2) whether the woman’s urine 
sample was taken upon admission.  
 
Only one indicator, whether the woman’s urine sample was taken, met both study validity criteria (AUC: 
0.6717± 0.04, IF: 0.97). A urine sample screen is an early test for preeclampsia/ eclampsia, or 
Box 2A: Cross-tabulation: Urine sample taken at admission. 
Did someone ask you to give them a urine sample at or near your 
admission to the facility? 
     Observer Report (Number) 
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 No  Yes  Total 
No 361 72 433 
Yes 67 72 139 
Total 428 144 572 
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elevated blood pressure in the mother which can lead to deadly seizures, one of the leading causes of 
maternal mortality and morbidity. Despite meeting both study validity criteria, the urine screen indicator 
had moderately low sensitivity (50%), indicating that only half of women whose urine sample was taken 
reported that the intervention took place (Box 2A). However, the indicator did have high specificity 
(84%), indicating that a large proportion of women who did not have their urine sample taken accurately 
reported that the intervention did not occur. Since urine screening test can identify a potentially life-
threatening complication, the low sensitivity of the indicator signifies it would not capture critical 
information.  
 
The indicator “HIV status checked” met only the IF validity criteria. The underreporting of true cases 
(55% sensitivity) and false positives among negative cases (1-specificity, 52%), however, balances out, 
so the IF approximates the population-based prevalence that would be obtained via household survey 
(AUC: 0.5129± 0.04, IF: 0.78).   
 
Initial assessment practices that we were unable to assess by robust analysis because of near universal 
or rare occurrence of the intervention included: (1) provider hand washing or antiseptic use before 
initial examination of the woman, (2) whether high-level disinfected or sterile gloves were worn for 
vaginal examination, (3) whether the woman’s blood pressure was taken, (4) whether the woman was 
offered or (5) received an HIV test, and (6) whether the fetal heart rate was checked with a 
fetoscope/ultrasound (Annex A, Tables 1-2). Descriptive results for these indicators show that nearly all 
women received and positively reported receiving these standard practices of care. However, of the 
relatively few women who did not receive such interventions, nearly all falsely reported that these 
interventions took place, resulting in low specificity rates, <10%. As a result, women overestimated 
indicators of provider hand washing or antiseptic use (96% self-report prevalence compared to 2% 
observed prevalence), being offered an HIV test (14% self-report prevalence; 2% observed prevalence), 
and receiving an HIV test (16% self-report prevalence; 1% observed prevalence).  
 
INITIAL ASSESSMENT: SUMMARY 
1 of 2 assessed indicators of facility-based care received met study criteria for valid 
measurement― whether a urine sample was taken. While this indicator had high accuracy in 
accurately classifying women who did not receive the intervention, its sensitivity of 50% 
suggests that nearly half of women who received the intervention were not identified. An 
indicator on whether HIV status was checked met the IF criteria only. 
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Respectful Care 
 
Five indicators reflected aspects of women-centered care (proxy for respectful care), including whether 
the woman was: (1) allowed to drink liquids or eat, (2) encouraged or assisted to ambulate during labor, 
(3) encouraged or assisted to assume different positions in labor, (4) allowed to have a support person/ 
companion present during labor and delivery, and (5) whether a support person/ companion was 
actually present during labor or birth.  
 
In general, the majority of proxy measures of respectful or woman-centered care were not observed to 
take place (e.g., being able to eat or drink during labor, being allowed or having a support companion 
during labor and delivery). A correspondingly low proportion of women reported that such interventions 
took place, limiting the ability to conduct full analysis. Only one indicator, whether the woman was 
encouraged or assisted to ambulate during labor, had sufficient numbers for robust analysis. 
Specifically,  being encouraged or assisted to ambulate in labor was observed to occur among 22% of 
women, while it was reported by only 8%. This indicator did not meet study validity criteria (AUC: 
0.4966± 0.04, IF: 0.37) and was underreported by women.  
 
 PROVIDER RESPECTFUL CARE: SUMMARY 
Only 1 of 5 indicators could be assessed by robust analysis─ whether the woman was encouraged to 
ambulate during labor. This indicator did not meet study validity criteria and was particularly 
underreported by women.    
 
 
Induction / Augmentation of Labor 
 
 Induction of labor 
 
Approximately 17% of all women reported 
“someone did something” to bring on their labor, 
rather than their labor starting spontaneously. Of 
women who reported that someone intervened 
(n=91), the majority (79%) reported receiving 
medication through an IV line in their arm; while 21% reported their membranes were ruptured. We 
were unable to assess the validity of receiving membrane rupture for induction of labor, since observers 
Box 3A. Cross-tabulation: Induction of labor by uterotonic. 
2-item indicator constructed: 1) someone intervened to bring on 
labor and 2) medication through IV was given to bring on labor. 
(Proxy for observer report of uterotonic given). 
     Observer Report (Number) 
Induces labor with uterotonic 
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 No  Yes  Total 
No 440 47 487 
Yes 54 18 72 
Total 494 65 559 
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did not record the indication for receiving this intervention (i.e., whether performed for induction or 
augmentation of labor).  
 
To assess the validity of ‘received a uterotonic for labor induction’, we constructed a two-item indicator 
of women who reported “something was done to bring on labor” and who subsequently reported 
receiving a uterotonic (i.e., medication through an IV line, as no option for intramuscular injection was 
given) to bring on labor (13%). This indicator was compared to observer reports of whether the woman 
received a uterotonic to induce labor (12%) (Box 3A). This indicator did not meet the AUC validity criteria 
(AUC: 0.5838± 0.04, IF: 1.11). In particular, this indicator had low sensitivity (28%), indicating that not 
all women who received a uterotonic for labor induction reported receiving the intervention (Annex B). 
However, the indicator did meet the IF criteria, indicating that it may be acceptable to approximate the 
population-based prevalence. 
 
We also sought to assess whether women could accurately report on the method by which a uterotonic 
for labor induction was received. Robust analysis, however, was not possible since all observers 
indicated that women received the uterotonic through an IV line.  
 
Augmentation of labor 
 
More than half (52%) of all women reported “someone did something to strengthen or speed up” their 
labor. The most common method of uterotonic administration reported for augmentation of labor was 
an IV line inserted in the arm (both womens’ and observers’ report). 
 
A two-item indicator in which women who reported 
“something was done to speed up or strengthen 
labor” and who subsequently reported receiving a 
uterotonic (i.e., an injection or medication through 
an IV line) to strengthen labor (42%) was 
compared to the observer report of the woman 
receiving a uterotonic to augment labor (75%) 
(Box 4A). This indicator did not meet the IF criteria 
(AUC: 0.6539± 0.04, IF: 0.56). Similar to receiving 
a uterotonic for induction of labor, this indicator 
had relatively low sensitivity (50%), indicating that not all women who received a uterotonic for the 
augmentation of labor reported the intervention.  
Box 4A. Cross-tabulation: Augmentation of labor by uterotonic. 
2-item indicator constructed: 1) someone intervened to 
strengthen labor and 2) received medication through an injection 
or IV line to speed up or strengthen labor.  
(Proxy for observer report of uterotonic given). 
     Observer Report (Number) 
Augments labor with uterotonic 
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 No  Yes  Total 
No 95 179 274 
Yes 22 176 198 
Total 117 355 472 
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All women who received a uterotonic for labor augmentation received it by IV line, so robust analysis for 
this indicator was not possible. Cross-tabulation results suggest that women are not able to accurately 
report on the method of augmentation of labor. Specifically, only slightly more than half of women (57%) 
who were observed to receive medication via IV line for labor augmentation reported receiving the 
intervention via this route. 
 
Injection or IV medication during labor 
 
In addition to being asked to specify the method 
by which their labor was brought on or 
strengthened, women were asked a general 
indicator on whether “before the birth of the 
baby, did you receive an injection or IV 
medication during labor?” This indicator was 
used as a proxy measure for receiving a 
uterotonic for the induction or augmentation of 
labor (no providers administered uterotonic in 
tablet form). In contrast to the observer report on receiving a uterotonic (by injection or IV line) for labor 
induction or augmentation, this indicator met both study validity criteria (AUC: 0.6349± 0.04, IF: 0.84) 
(Box 4B). 
 
A comparison indicator (which was constructed 
in analysis to combine women’s responses to 
two survey questions) that compared women’s 
self-report of whether an injection or IV 
medication was received for either induction or 
augmentation of labor did not meet either study 
validity criteria (AUC: 0.6947± 0.04, IF: 0.65). 
Specifically, this indicator had lower sensitivity 
(59%), indicating that not all women who 
received a uterotonic by injection or IV 
medication reported receiving either 
intervention for the purposes of bringing on or 
strengthening labor (Box 4C). 
 
Box 4B. Cross-tabulation:  Uterotonic for induction or augmentation 
of labor (general indicator). 
Before the birth of your baby, did you receive any injection or IV 
medication during labor? 
 Observer Report (Number) 
Composite indicator of whether observer reported IV or 
injection for induction or augmentation of labor. 
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 No  Yes  Total 
No 78 130 208 
Yes 59 304 363 
Total 137 434 571 
Box 4C. Cross-tabulation: Uterotonic for induction or augmentation of 
labor (composite indicator). 
Composite indicator of whether women reported receiving an 
injection or IV medication for induction or augmentation of labor 
(constructed in analysis). 
 Observer Report (Number) 
Composite indicator of whether observer reported 
IV or injection for induction or augmentation of 
labor. 
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 No  Yes  Total 
No 91 148 239 
Yes 23 214 237 
Total 114 362 476 
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Taken together, these results suggest that at an individual classification level women can report 
whether they received an injection or IV medication at some point during labor before delivery, but not 
the indication for the medication (whether received for induction or augmentation of labor). An indicator 
on whether a uterotonic was received for the induction of labor may be appropriate for measuring 
population-based coverage of this practice. 
 
Membrane rupture (induction or augmentation of labor) 
 
27% of all women reported receiving membrane rupture (either for induction or augmentation of labor), 
compared to 57% of observers reporting this intervention. Given the relatively low sensitivity of the 
indicator (38%), the indicator meet only the AUC validity criteria (AUC: 0.6333± 0.05, IF: 0.47). The low 
sensitivity of the indicator indicates that the majority of women who received membrane rupture did not 
report it.  
 
INDUCTION & AUGMENTATION OF LABOR: SUMMARY 
Results suggest women may be able to report on whether an injection or IV medication was received at 
some point during labor before delivery, but not the indication for the medication (for induction or 
augmentation of labor). Women did not report accurately on whether membrane rupture was received 
for the induction or augmentation of labor at the population level.  
 
Uterotonic for Prevention of Postpartum 
Hemorrhage (PPH) (Post-delivery) 
 
Active management of the third stage of 
labor (AMTSL), which includes administration 
of a uterotonic following delivery, is a critical 
intervention to prevent postpartum 
hemorrhage, a leading contributor to 
maternal mortality and morbidity.22 Nearly all 
women received a uterotonic following 
delivery (99%), and nearly two-thirds (64%) received the medication within 3 minutes of birth. All 
uterotonics were administered via IV line, most often by IV drip (93%), a bolus injected into an IV line 
(6%), or an IV drip combined with intramuscular injection (<1%).  
 
Box 5A. Cross-tabulation: Received prophylactic uterotonic (Y/N). 
In the first few minutes after the delivery of your baby, did anyone give you… (1) 
an injection in the thigh or buttock? (2) medication intravenously through a tube 
in your arm? (3) tablets to swallow or hold in your mouth or placed in your 
rectum? (Select all) 
Observer Report (Number) 
Uterotonic administered (Y/N) 
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 No  Yes  Total 
No 0 232 232 
Yes 4 357 361 
Total 4 589 593 
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To assess women’s ability to accurately report whether a uterotonic for the prevention of postpartum 
hemorrhage was administered following delivery, women were asked, “In the first few minutes after the 
delivery of your baby, did anyone give you an injection in your thigh or buttock, medication intravenously 
(through a tube in your arm) or tablets to swallow, hold in your mouth, or placed tablets in your 
rectum?” (option to select all applicable interventions received). 
 
It was not possible to conduct robust analysis of this indicator, given that nearly all women received the 
intervention. Cross-tabulation results (Box 5A) indicate that of women who received the intervention, 
less than two-thirds reported receiving it (sensitivity: 61%). These results suggest that the composite 
proxy indicator constructed to assess whether women were administered a uterotonic for PPH did not 
capture a substantial proportion of women who received the intervention.  
 
Timing of uterotonic administration for PPH 
 
To examine whether women could 
accurately report on the timing in which 
the uterotonic was received, we 
assessed women’s self-report of 
whether any IV medication, injection in 
the thigh or buttocks, or tablets (oral, 
vaginal or rectal) were received 
immediately (in the first few minutes) 
following birth. This composite proxy 
indicator was compared to the observer 
report of whether the uterotonic was 
administered up to 3 minutes following birth. This indicator met only the IF study validation criteria (AUC: 
0.5106± 0.04, IF: 0.95). Specifically, of women who were observed to receive the prophylactic 
uterotonic within this time frame, 61% reported it. The moderate sensitivity level indicates that a 
considerable proportion of women did not report the intervention when it in fact took place. The 
indicator was also marked by a high degree of false positive reporting (i.e., low specificity). Over half of 
women (59%) who did not receive the intervention within 3 minutes of delivery falsely reported that it 
took place (Box 5B). These results suggest that at an individual level, this indicator is unlikely to be 
validly reported, as both underreporting of true cases and false positive reporting among negative cases 
occurs.  However, at a population-level, IF results indicate the low sensitivity and specificity cancel out 
and the indicator produces an acceptable estimate of the population-based prevalence. 
 
Box 5B. Cross-tabulation: timing of prophylactic uterotonic (1-3 minutes post-
delivery). 
In the first few minutes after the delivery of your baby, did anyone give you… (1) 
an injection in the thigh or buttock? (2) medication intravenously through a tube 
in your arm? (3) tablets to swallow or hold in your mouth or placed in your 
rectum? 
                         Observer Report (Number) 
Uterotonic administered 1-3 minutes following birth 
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 No  Yes  Total 
No 85 143 228 
Yes 124 228 352 
Total 209 371 580 
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We also examined the accuracy of women’s self-reports of whether the prophylactic uterotonic was 
received following the delivery of the placenta. For this comparison, we assessed women’s report on 
whether any IV medication, injection in her thigh or buttocks, or tablets (oral, vaginal or rectal) were 
given in the first few minutes after the delivery of the placenta. We compared this proxy indicator to the 
observer report on whether the uterotonic was received up to 3 minutes following the delivery of the 
placenta. A high proportion of women (94%) reported receiving IV medication, an intramuscular 
injection, or tablets following the delivery of the placenta. In contrast, only one-fifth of women (20%) 
were observed to receive a prophylactic uterotonic following the delivery of the placenta. The proxy for 
women’s self-report on receiving prophylactic uterotonic following the delivery of the placenta had high 
sensitivity (96%), demonstrating nearly all women who received the intervention were able to report it. 
However, the indicator was marked by a high false positive rate (94%) and did not meet either study 
validation criteria criteria (AUC: 0.5097± 0.04, IF: 4.71). 
 
Method of uterotonic administration 
 
All observers reported that the prophylactic uterotonic was administered by IV line (either by IV bolus, IV 
drip, or IV drip plus IM injection), compared with 61% of women. There was not sufficient variation to 
assess the accuracy of women’s reporting by delivery method. However, cross-tabulation results show 
that of the women who received uterotonic by IV line (any IV method) (n=498), less than two-thirds 
report having received medication by this administration route (specificity: 61%).  
 
Type of uterotonic 
 
The most common type of uterotonic 
administered was oxytocin (97%), followed by 
ergonovine and carbetocin. Since oxytocin was 
the standard medication administered, robust 
analysis was not possible. However, cross-
tabulation results demonstrate that of women 
who received oxytocin, 50% of women 
accurately reported receiving the medication by its brand name (Box 5C). 
  
Box 5C. Cross-tabulation: Oxytocin received after birth. 
Immediately after the birth of your baby, did anyone give you 
medication called oxytocin to help your womb become firm? 
Observer report (Number) 
 
S
e
lf
-r
e
p
o
rt
 
(N
u
m
b
e
r)
 
 No Yes Total 
No 1 178 179 
Yes 2 177 179 
Total 3 355 358 
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Since oxytocin was the uterotonic 
administered to nearly all women and its route 
of administration was by IV line (97%), we 
compared women’s self-report of receiving a 
uterotonic by administration route  (assessed 
by a proxy composite measure of ‘yes’ to 
whether the woman received any of the 
following: (1) an injection in the thigh or 
buttock, (2) medication intravenously through 
a tube in arm, (3) or tablets given orally or 
rectally in the first few minutes following birth), 
and their reporting ‘yes’ to the question “after 
the birth of your baby, did anyone give you a 
medication called oxytocin to help your womb 
become firm or contract?”.   
 
The cross-tabulation results of women’s self-report on these two indicators are presented in Box 5D.  
While only descriptive analysis was possible, these results demonstrate that 85% of women (125 out of 
147) who reported receiving medication by IV line following delivery also reported receiving oxytocin. Of 
note is that 85% (52 out of 61) of women who reported receiving IV medication following delivery did 
not report receiving oxytocin. To determine whether these women had in fact received oxytocin 
(highlighted cell, Box 5D), we conducted a cross-tabulation with the observer report. Data show that all 
but one of these women (99%) received oxytocin by IV line. Therefore, 51 of the 52 women were correct 
in noting they had received an IV line, but incorrect in not indicating that they had received oxytocin. 
These results suggest not all women can report on receiving a uterotonic by name.  
 
UTEROTONIC FOR THE PREVENTION OF POSTPARTUM HEMORRHAGE: SUMMARY 
Nearly all women received oxytocin via IV line following delivery, meaning there was insufficient variation 
to assess whether a woman can report receiving a uterotonic for the prevention of postpartum 
hemorrhage, the route of administration, or the name of the drug. Cross-tabulation results, however, 
suggest that a large proportion of women who received a uterotonic would not be captured using a 
composite study indicator. Descriptive results also suggest that women are unlikely to be able to report 
on receiving oxytocin by name. The timing in which the uterotonic was received (in the first few minutes 
of birth or after the delivery of placenta) was robustly analyzed and did not meet criteria for valid 
Box 5D. Cross-tabulation (Self-Report): Prophylactic uterotonic and 
oxytocin. 
Q1. In the first few minutes after the delivery of your baby, did anyone 
give you… (1) an injection in the thigh or buttock? (2) medication 
intravenously through a tube in your arm? (3) tablets to swallow or hold 
in your mouth or placed in your rectum? 
Q2. Immediately after the birth of your baby or sometime before the 
delivery of the placenta, did anyone give you a medication called 
oxytocin? (*constructed in analysis*)  
    Self-Report (Number) 
   Q2. 
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.  No oxytocin Yes 
oxytocin 
Total 
Injection 9 21 30 
IV line 52 125 177 
Tablet 0 1 1 
Total 61 147 208 
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reporting at the individual level. IF results suggest the indicator on whether a uterotonic was received 
within 3 minutes after delivery could approximate the population-based prevalence.  
 
 
Active management of the third stage of labor 
 
Active management of the third stage of labor for the prevention of postpartum hemorrhage includes 3 
components: (1) administration of a uterotonic for PPH, (2) controlled cord traction, and (3) uterine 
massage immediately following delivery of the placenta. Robust analysis was possible only for whether 
uterine massage was performed immediately following delivery of the placenta. This indicator had 
moderately high sensitivity (80%) and low specificity (20%), indicating that approximately 20% of women 
who received uterine massage following delivery of the placenta were not captured by the indicator and 
80% of women who did not receive the intervention reported that it had taken place. Given that nearly 
all women received and reported receiving prophylactic uterotonic and controlled cord traction, it was 
not possible to assess these indicators using robust analysis. However, cross-tabulation results indicate 
that a substantial proportion (38%) of women did not report receiving a uterotonic following delivery, 
although they were observed to do so. Controlled cord traction was also a near universal practice, which 
limited the ability to conduct robust analysis. Most women who received controlled cord traction 
reported it (sensitivity: 94%), but of the few cases where controlled cord traction was not implemented, 
there was a high degree of false reporting (95% false positive reports). 
 
A composite indicator of the 3 essential 
components of the active management of the 
third stage of labor (AMTSL) was assessed. 
This indicator did not meet the AUC study 
validity criteria (AUC: 0.4986± 0.04, IF: 0.93) 
Cross-tabulation results in Box 6 indicate that 
approximately one-quarter of women who 
received all 3 components of care were not 
captured by the indicator (sensitivity: 75%). Additionally, about three-quarters of women who did not 
receive all 3 elements of care reported that they had (1- specificity: 76%).  The AMTSL composite 
indicator, however, did meet IF criteria, suggesting it may be suitable for assessing population-based 
coverage of the practice. 
 
Box 6. Cross-tabulation: All 3 components of AMTSL received. 
Prophylactic uterotonic + controlled cord traction + uterine massage 
following delivery of placenta received.  
        Observer Report (Number) 
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 No Yes Total 
No 24 109 133 
Yes 76 340 416 
Total 100 449 549 
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ACTIVE MANAGEMENT OF THE THIRD STAGE OF LABOR: SUMMARY 
A composite indicator on whether 3 essential elements for active management of the third stage of 
labor—uterotonic for the prevention of postpartum hemorrhage, controlled cord traction, and uterine 
massage following delivery of the placenta—did not meet study validity criteria. The indicator was both 
under- and overreported by women. The composite AMTSL indicator did meet the IF criteria, indicating a 
close approximation of the population-based prevalence of the practice. 
 
 
Skilled Birth Attendance 
 
Skilled provider during labor and delivery 
 
Both observers’ and women’s self-reported coverage of skilled birth attendance [defined as a general 
“doctor” category, doctor subcategories (identified as an ob-gyn specialist, a medical resident or general 
practitioner), or a nurse] was high for the primary birth attendant during labor and delivery and for the 
provider who delivered or ‘caught’ the newborn during birth (>90%). Given the near universal 
occurrence of this practice, it was not possible to conduct robust analysis. Cross-tabulation data, 
however, indicate that nearly all women observed to have a skilled provider ‘catch’ their newborn at 
birth correctly reported it as such (specificity: 97%). A similarly high proportion of women observed to 
have a skilled birth attendant as their primary provider in labor (97%) or delivery (93%) also identified 
the level of their provider as such. However, the vast majority of women not observed to receive skilled 
birth attendance at each of these stages falsely reported receiving skilled attendance, indicating low 
indicator specificity (>90% false positive reporting across birth phases). These results should be 
interpreted with caution given the small number of women who did not receive skilled birth attendance 
(n=19 in labor; 42 in delivery), since the lack of variation in the data prevented full analysis.  
 
Main provider who assisted in delivery 
 
Most deliveries were attended by medical residents (90%) as the primary provider, followed by medical 
interns (7%), general practitioners or ob-gyns (2%), and nurses (<1%) (observed prevalence, excluding 
‘Don’t Know’ responses). The vast majority of women reported a doctor as the primary provider during 
their delivery (93%), without being able to define the category to which the medical provider belonged to 
(i.e., ob-gyn, medical resident, and general practitioner or medical intern). Specifically, of the 542 
women who reported a doctor as their main provider during delivery 40 (7%) providers were actually 
medical interns (Table 2). 
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In Mexico, there is little distinction between 
doctor categories; however, while medical 
residents are considered skilled attendants, 
medical interns are not. We assessed a 
combined indicator of whether the main 
provider during delivery belonged to any 
doctor subcategory of skilled provider (i.e., ob-
gyn, medical resident, or general practitioner) (Box 7). While robust analysis was not possible, cross-
tabulation results show the indicator would have high sensitivity (96%). Cross-tabulation results in Table 
2 suggest women may be unable to distinguish the presence of less prevalent, unskilled providers, such 
as medical interns. The discrepancy in reporting may reflect differences in how the ‘main’ provider was 
conceptualized by women in comparison to observers. For example, it is possible that women identified 
the ‘main’ provider as the highest-ranking attendant present during delivery.  Observers, instead, 
identified the ‘main’ provider as the provider who spent the most time, or administered the majority of 
care received by the woman. Additionally, given the low prevalence of instances when the main provider 
was not a doctor/ob-gyn or medical resident, without near-perfect specificity these indicators are likely 
to be overreported. 
 
Main provider who ‘caught’ the newborn  
 
In addition to identifying their main provider during delivery (“Who was the main provider assisting you 
during delivery?”), women were asked, “Who was the main provider who actually delivered your baby 
(caught the baby)?” The majority of providers who ‘caught the newborn’ following delivery were either 
doctors/ob-gyns or medical residents (90% self-report compared to 91% observed prevalence). Of the 
TABLE 2. Cross-tabulation: Main provider during delivery. 
Self- Report  (Number) 
Observer Report (Number)  
Doctor 
/Ob-gyn  
Medical 
resident  
Medical 
Intern  Nurse  
Student 
Nurse  Other  Total  
 
Doctor /Ob-gyn 14 487 40 1 0 0  542 
 
Medical resident  0 17 0 0 0  0  17 
 
Medical intern  0  11 2 0  0  0  13 
 
Nurse  0  11 0 1 0  0 12 
 
Student nurse  0  0 0  0 0  0  0 
 
Don’t Know 0  9 2 0 0  0  11 
 
Total  14  535 44 2 0 0  595 
Box 7. Cross-tabulation. Main provider during delivery—doctor /ob-gyn 
or medical resident. 
Observer report (Number) 
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 No Yes Total 
No 3 22 25 
Yes 41 510 511 
Total 44 532 576 
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485 women who reported that the provider who caught their newborn was a doctor, 9% were either 
medical interns or nurses.  
 
It was possible to validate a combined indicator on the category of birth attendant who ‘caught’ the 
newborn during delivery as a doctor/ob-gyn or medical resident. This indicator did not meet the AUC 
criteria (AUC: 0.5203± 0.04). Specifically, at an individual classification level, the combined doctor/ob-
gyn/medical resident indicator was marked by high sensitivity (90%) and low specificity (14%). These 
results indicate women had low accuracy in reporting when the main provider did not belong to one of 
the skilled provider doctor subcategories (doctor or medical resident), and instead was some other less 
common type of provider (e.g., nurse, student nurse, or medical intern). However, at the aggregate level 
for this indicator, differences in sensitivity and specificity canceled out to produce an acceptable IF level 
(IF: 0.98). The IF result of close to 1 highlights the potential of the indicator to obtain an acceptable 
population-based coverage estimate of the provider category.   
 
Main provider labor 
 
Similar to delivery, the most prevalent providers during labor were medical residents or doctors/ob-gyn 
(82% self-report and 96% observed prevalence). Of the 501 women who reported a doctor was the main 
provider during labor, 12% were either medical interns, nurses, or student nurses (Table 3). The 
combined indicator on whether the provider was a doctor/ob-gyn or medical resident during labor was 
robustly analyzed. The indicator did not meet study AUC validity criteria (AUC: 0.5477± 0.04), with high 
sensitivity (82%) and notably low specificity (27%). The indicator did meet IF criteria, suggesting the 
potential for this indicator to obtain acceptable population-based estimates of coverage of a doctor/ob-
gyn during labor (IF: 0.85) at an aggregate level. 
  
TABLE 3.  Cross-tabulation:  Main provider during labor. 
Self-report 
(Number) 
Observer Report (Number)  
Doctor/ 
ob-gyn  
Medical 
resident  
Medical 
Intern  Nurse  
Student 
Nurse  Other  Total  
 
Doctor /ob-gyn 7 423  12  56  3 0  501 
 
Medical resident  3  26  1  0  0  0  30  
 
Medical intern  0  19  2  0  0  0  21  
 
Nurse  0  76 4  0  0  0 80 
 
Student nurse  0  4  0  0 0  0  4 
 
Don’t Know 0  10  0  0 0  0  10 
 
Total  10  558 19  56  3 0  646  
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Additional providers during delivery 
 
In addition to identifying their primary provider during labor and delivery, women were asked to list all 
additional providers who were present both in labor and delivery. For delivery, the next most common 
additional provider was a doctor (80% self-report), followed by a nurse (81%), medical student or intern 
(26%), and medical resident (14%). Women also specified an ‘other’ option, and listed specific types of 
doctors such as a pediatrician (39%) or anesthesiologist (10%) as also present. Because women and 
observers were asked to report all types of providers present, rather than specifying one main provider, 
there were sufficient numbers to assess the accuracy of women’s self-report of multiple categories of 
providers. 
  
Results of the validity analysis reflect the same trend as the primary provider findings, in that the 
majority of additional providers noted to be present during labor were doctors/ob-gyns or medical 
residents (82% self-report, 88% observed prevalence). Although the combined doctor/ob-gyn /medical 
resident indicator had a similar prevalence rate reported by women and observers, it was marked by low 
specificity (21%) and met only the IF validity criteria (IF: 0.93). Other indicators of additional providers 
during delivery or labor that met the IF validity criteria alone were whether additional providers were a 
nurse or nursing student. 
 
Additional providers—skilled 
 
The near universal presence of a skilled provider (doctor of any type, or nurse) as an additional provider 
in both labor and delivery limited our ability to conduct robust analysis. It is noteworthy; however, that 
almost all of the handful of women who were not observed to have a skilled provider as an additional 
provider present during labor or delivery falsely reported the presence of one. This finding should be 
interpreted with caution since there were few cases in which an additional skilled provider was not 
present during labor and delivery.  
 
Skilled birth attendant: summary 
 
In summary, across birth phases and provider roles, the category of provider most commonly observed 
to be present during labor and delivery were skilled provider doctors (i.e., ob-gyns, general practitioners, 
or medical residents) either as the primary provider or as an additional provider present. Since there is 
little distinction in Mexico between these doctor subcategories, including medical residents, a combined 
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indicator was assessed. No composite doctor/ob-gyn /medical resident indicator met both validity 
criteria. Across birth phases the combined doctor indicator had low specificity, indicating that women 
were likely to report any doctor category as the main provider or as an additional provider who was 
present when they were not. Results from ‘other providers’ present during labor or delivery, for which 
robust analysis was possible, also reflected these findings. Given the low prevalence of other types of 
providers present during labor and delivery, without near-perfect specificity these indicators are likely to 
be overestimated by women at the individual level. However, across birth phases and provider roles, 8 
birth attendant indicators met the IF criteria alone. They included whether the main provider who caught 
the newborn during delivery was a doctor/ob-gyn or medical resident. Birth attendant indicators that 
met the IF criteria alone may be useful for population-based coverage of these provider types. Given 
that the fine distinction between subcategories of doctors (i.e., ob-gyn, general practitioner, or medical 
resident) is likely less programmatically useful than assessing the prevalence of skilled attendance, the 
composite doctor indicator may be of particular use.  
 
Number of providers who attended birth 
 
The number of providers who attended the woman’s 
birth was observed to range from 1 to 12 (mean: 4 ± 
2).  Approximately half of women were attended by 
more than 4 providers (45% true prevalence) during 
their delivery, while 75% of women were attended 
by six providers or fewer. The average number of 
providers who attended the birth by women’s self-
report was higher (mean: 6 ± 3) and ranged from 2 
to 22, reflecting the trend for women to overreport 
the number of providers present (Figure 2).  
Women’s self-reports and observers’ reports on the number of providers present were weakly correlated 
(r=0.2, p<0.001). No indicators of the number of providers who attended the birth met both study 
validity criteria. In general, women’s self-report of the number of providers present at their birth were 
marked by high rates of false positive reporting (i.e., low specificity) (Annex B).  
 
SKILLED BIRTH ATTENDANT: SUMMARY 
In contrast to other settings, in Mexico doctors and medical residents attend the vast majority of births 
in hospital settings, and both are considered skilled providers. An indicator that combined these skilled 
doctor sub-categories did not meet both validity criteria, irrespective of delivery phase and provider role 
FIGURE 2. Scatterplot: Women’s and observers’ report 
on the number of providers who attended the birth. 
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(main provider or additional provider present). Across birth phases the combined doctor indicator had 
low specificity, indicating that women were likely to report any doctor category as the main provider or 
as an additional provider who was present when they were not. Given the low prevalence of other types 
of providers, without near-perfect specificity (i.e., true negative classification) these indicators are likely 
to be overestimated by women at the individual level. However, across birth phases and provider roles, 
8 birth attendant indicators did meet the IF validation criteria, including whether the main provider who 
caught the newborn during delivery was a doctor/ob-gyn/medical resident. These indicators may be 
useful for estimating population-based coverage of these provider types.  
 
 
Immediate Newborn Care 
 
Three indicators of immediate newborn care had sufficient variation for validity analysis: (1) whether the 
baby was given to the mother immediately after birth, (2) whether the newborn was breastfed within the 
first hour after birth, and (3) whether something other than breastmilk was given to the baby to eat or 
drink in the first hour after birth.  
 
None of these indicators met both study validity criteria. For all 3 indicators, women’s self-reported 
prevalence exceeded the observed prevalence. While the indicator of breastfeeding in the first hour 
after birth had fairly high sensitivity (81%), it was also marked by only moderate specificity (44%), 
indicating that nearly 60% of women not observed to breastfeed in the first hour after birth falsely 
reported that they had. The indicators of whether the baby was immediately placed with the mother 
after birth and whether the baby was given something other than breastmilk to eat or drink in the first 
hour after birth were marked by both moderate sensitivity and specificity (Annex B), indicating both the 
underreporting of true cases and false reporting of true negative cases. The reporting discrepancies 
may reflect differences in how women understood the terms ‘immediately’ or the ‘first hour’ after 
delivery. 
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Newborn thermal care 
 
A high proportion of newborns were immediately dried 
following delivery (94% observed prevalence). Since 
nearly all mothers also reported that their newborns 
were immediately dried (99%), robust analysis was 
not possible.  
 
Although validity analysis was also not possible for 
other indicators of newborn thermal care, results 
suggest indicator wording has important implications 
for women’s reporting accuracy. Specifically, almost 
no observers (<1%) reported the newborn was placed 
skin-to-skin against the mother’s chest following 
delivery. However, 11% of women reported that this 
practice took place, reflecting a substantial degree of false reporting (Box 8). A two-item indicator which 
included women who positively answered “Did someone place the baby on your chest, against your skin 
immediately after delivery” and subsequently reported the baby was lying naked against the skin to the 
item “Was your baby wrapped in a towel while lying against your chest or lying naked against your skin,” 
reduced false positive reporting. Women’s reported prevalence to the two-item skin-to-skin indicator 
(1%) better approximated the observer report (<1%).  
 
Instead of being placed naked skin to skin with the mother and then draped with a cloth, the standard 
practice at the Mexico facility was for babies who were breathing at birth to be first wrapped with a 
towel or cloth (99%). Babies were then brought near the mother for her to kiss on the cheek. This 
contact with the baby may have confused women when asked about skin-to-skin contact. In addition, 
because the practice of wrapping the newborn after birth was near universal, it was not possible to 
assess the accuracy of women’s reporting on this indicator. However, cross-tabulation results show that 
almost all of the women whose baby was not placed naked against their skin and was instead wrapped 
in a towel accurately reported these circumstances (99%). These results should be interpreted with 
caution since full validity analysis was not possible, and all babies not placed directly on the mother’s 
skin were covered with a towel (in matched data).  
 
Because the practice of bathing the baby within the first hour after birth rarely occurred, we were unable 
to fully assess this practice (3% observed prevalence; <1% self-report prevalence). However, descriptive 
Box 8. Cross-tabulation (Self-Report): Newborn skin-to- skin 
indicators.  
Q1. Did someone place the baby on your chest, against your skin 
immediately after delivery? 
Q2. Was your baby wrapped in a towel while lying against your 
chest or naked against your skin? 
    Q2. Self-Report (Number) 
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 Wrapped in 
towel 
Naked 
on Skin 
Total 
Not 
skin-to-
skin 
0 0 0 
Yes, 
skin-to-
skin 
54 8 62 
Total 54 8 62 
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cross-tabulation results indicate high specificity for this indicator, that is, of the 429 newborns not 
bathed within the first hour, 426 women correctly reported their newborn was not bathed (99% 
specificity). 
 
Composite indicator of essential newborn care 
 
A composite indicator of 3 essential elements of newborn care (newborn was immediately dried, placed 
skin-to-skin on mother’s chest, and breastfed in first hour) was constructed in analysis. This indicator 
had a 10% self-reported prevalence by women and 0% observed prevalence. The zero observed 
prevalence of the composite measure is due to the fact that only one newborn was observed to be 
placed naked against the mother’s skin immediately following delivery. Using the two-item skin-to-skin 
item in this composite indicator greatly reduced the reporting of false positives (<1% self-reported 
prevalence).   
 
IMMEDIATE POSTPARTUM NEWBORN CARE: SUMMARY 
We were able to assess 3 indicators of immediate newborn practices: whether the baby was placed with 
the mother immediately following birth, whether breastfeeding was initiated within the first hour of birth, 
and whether something other than breastmilk was given to the baby to eat or drink within the first hour 
of birth. No indicators met both study validity criteria. Question wording and order may have significant 
implications for the validity of indicators of newborn thermal care.  
 
 
Maternal Outcomes 
 
Complications 
 
Women were asked whether they experienced any of the following symptoms either during or 
immediately following delivery: (1) high blood pressure, seizures, blurred vision, severe headaches, (2) 
swelling in hands or face, (3) baby was in distress/ too large, (4) long labor (more than 12 hours), (5) 
excessive bleeding, (6) infection (fever), (7) another type of complication (specify), or (8) no 
complications.  Over one-third (38%) of women reported experiencing some type of complication, 
exceeding the observed prevalence (14%) by nearly 3 times. Women’s report of experiencing any type of 
complication did not meet study validity criteria (Annex B). Self-reports of experiencing any complication 
had a sensitivity of 61%, indicating that nearly 40% of women who had in fact experienced a 
complication did not report it. The indicator also had moderately low specificity (65%), reflecting a high 
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rate of false positive reports by women. Specifically, over one-third of women (35%) who had not 
experienced a complication falsely reported experiencing one.  
Box 9A. Descriptive frequencies: Complications.   
Did you experience any of the following complications during 
or after your delivery? (List all) 
Record whether mother had any of the following 
complications. (Select all) 
      Number Percent  Number Percent 
High blood pressure, seizure, blurred 
vision, severe headache, swelling in 
hands/face                         150 25.05 Pre-eclampsia/ eclampsia 14 2.32 
Excessive bleeding   25 4.17 Hemorrhage 50 8.31 
Baby was in distress/ too large             44 7.35 Obstructed labor 5 0.83 
Long labor (more than 12 hrs) 51 8.51 Prolonged labor 13 2.13 
Infection (fever) 33 5.51 Sepsis 0 0 
Other 45 7.51 Other 6 0.99 
No complications 371 61.94 No complications 520 86.24 
Don’t Know 0 0 Don’t Know 1 1.2 
      
 
Women most commonly reported experiencing eclampsia (i.e., high blood pressure, seizures, blurred 
vision, severe headache and swelling in the hands or face) (25% self-reported prevalence), followed by 
long labor (more than 12 hours) (9%), the baby was in distress or too large (7%) (indicative of fetal 
distress or obstructed labor), infection (fever) (6%), and excessive bleeding (4%) (indicative of 
hemorrhage) (Box 9A).  An additional 8% of women reported some other type of complication, including 
indications of gestational diabetes (high sugar), preterm or overdue newborn, nausea or vomiting, or not 
becoming dilated enough to progress into labor.  
There was sufficient variation to assess the 
accuracy of women’s report of two 
complications: pre-eclampsia/ eclampsia and 
hemorrhage (APH + PPH). The second 
indicator met both study validity criteria (AUC: 
0.7261 ± 0.04, IF: 1.04).  It is noteworthy, 
however, that while this indicator had high 
specificity (95%), its sensitivity was moderate 
at 50%. These results suggest that while the 
hemorrhage indicator would have a very low false positive rate, it would also miss half of women who in 
fact experienced hemorrhage (Box 9B). However, the indicator did meet IF criteria, indicating that while 
it may not be suitable for the individual classification of women, it would generate an acceptable 
approximation of the population-based prevalence of the complication.  
Box 9B. Cross-tabulation: Complication of hemorrhage. 
Did you experience the following complication during or after your 
delivery? Excessive bleeding.  
Observer Report (Number) 
 
S
e
lf
-R
e
p
o
rt
 
(N
u
m
b
e
r)
 
 No Yes Total 
No 519 24 543 
Yes 26 24 50 
Total 545 48 593 
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The indicator of eclampsia did not meet study validity criteria and was in general overreported by 
women. Specifically, if assessed by a population-based survey, the indicator would exceed the observed 
prevalence of pre-eclampsia/eclampsia by over 9 times (IF: 9.1).  
 
Post-delivery health checks 
 
All women (100%) reported that the provider performed at least one of the following health checks in 
the first physical examination after delivery: (1) check for bleeding, (2) perineal exam, (3) check for 
involution (to see whether the womb was becoming firm), (4) took blood pressure, or (5) took 
temperature (Box 9C). Observers indicated that 99% of women experienced at least one of these 
checks. While there was insufficient variation in results to conduct validity analysis of this indicator, we 
were able to assess the accuracy of women’s report of receiving a specific post-delivery check, 
including: 1) bleeding, 2) examine the perineum, 3) temperature, 4) blood pressure, and 5) involution.  
 
No indicators of specific post-delivery health 
checks on the mother met both study validity 
criteria (Annex B). While each indicator had 
fairly high sensitivity (>90%) apart from a 
slightly lower sensitivity for the provider check 
on involution, each indicator was also 
characterized by low specificity (i.e., high rates 
of false positive reporting).  
 
These findings reflect a tendency for most 
women to report that the specific health checks 
took place, while observers did not report that the examinations occurred in all instances. Indicators of 
whether the provider took the woman’s blood pressure in the first physical examination following 
delivery and whether the provider took the woman’s temperature had notably low specificity levels 
(<10%), indicating that the vast majority of women who did not receive this care reported that they had. 
The low prevalence of instances when post-delivery health checks did not take place also indicates that 
without near-perfect negative classification by women, these indicators are likely to be overestimated. 
Another potential explanation for the discrepancy between observers’ and women’s report of postnatal 
maternal health checks may be due to differences in timing. For example, data collectors anecdotally 
noted that the first physical exam after birth would sometimes be delayed up to 2-3 hours following 
Box 9C. Descriptive frequencies: Post-delivery health checks. 
In the first physical examination after delivery did the provider look, ask about, 
or examine for: bleeding, perineal exam, involution, take blood pressure, or 
take temperature? 
      Woman, % Observer, % 
Yes to any of following checks in first 
physical examination post-delivery 100.00 99.30 
Check for bleeding                         87.46 80.51 
Did a perineal exam   90.10 75.09 
Checked to see whether womb was 
becoming firm (involution)             83.45 81.65 
Took blood pressure 93.38 95.59 
Took temperature 93.34 66.89 
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delivery, after study observation had concluded, or could have been conducted outside of the delivery 
ward, in which case they would not have been seen by observers.  
 
All indicators of immediate postnatal health checks on the mother (apart from whether the provider took 
the woman’s temperature in the first physical examination following delivery) met the IF criteria, 
suggesting that coverage of these indicators would approximate the population-based prevalence.  
 
Other maternal outcomes 
  
Other maternal outcomes assessed included whether the mother received an episiotomy, was given any 
blood products during her stay in the facility, and whether she asked for or received pain medication at 
any time. Each of these 4 indicators was assessed by robust analysis. Indicators of episiotomy and 
blood products given met both study validity criteria. 
Women reported receiving episiotomy with generally high accuracy (sensitivity: 98%, specificity: 63%, 
AUC: 0.8041± 0.03, IF: 1.15), and this indicator met both validation criteria. Although receiving blood 
products during the stay in the facility also met study validity criteria (AUC: 0.6706± 0.04, IF: 1.00), this 
indicator was marked by low sensitivity (36%), indicating that approximately 65% of women who had 
received blood products at some time during their stay did not report it. A woman requiring a blood 
transfusion is likely to be in critical health, possibly asleep or unconscious, which might cause women 
who received the intervention not to recall it.  
 
Neither asking for nor receiving pain relief medication during the facility stay met both study validity 
criteria. In particular, asking for pain relief medication was underreported by women (sensitivity: 33%, 
specificity: 79%), while receiving pain medication tended to be overreported by women (sensitivity: 90%, 
specificity: 20%), with a higher false positive rate. Whether the woman received pain relief medication 
meet only the IF criteria. 
 
MATERNAL OUTCOMES: SUMMARY 
Women’s report of whether any complication occurred did not meet both study criteria and would be 
overestimated nearly 3 times if assessed through a population-based survey. Indicators for two specific 
complications had sufficient variation for robust analysis: whether hemorrhage or eclampsia was 
experienced. The indicator of hemorrhage (whether excessive bleeding was experienced) met both 
study validity criteria, but was marked by low sensitivity, suggesting nearly half of hemorrhage cases 
would not be reported by women. However, the IF factor of approximately 1 indicates the indicator 
would produce an acceptable population-based estimate of hemorrhage. The indicator of eclampsia did 
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not meet the IF criteria and would likely be overestimated in a population-based survey. No indicator of 
postpartum health checks met both validity criteria. In general, women tended to report that health 
checks took place in all circumstances (regardless of whether they were observed to occur). The low 
prevalence of instances when health checks did not take place increases the potential for overreporting 
by women. 
Other maternal outcomes examined included receiving episiotomy, receiving blood products at some 
time during their facility stay, and asking for and receiving pain medication. Two indicators, receiving 
episiotomy and blood products, met both validity criteria. Receiving blood products, however, was 
notably underreported by women, and approximately 65% of women who had received blood products 
did not report receiving the intervention.  
 
 
 
Newborn Outcomes 
 
Newborn birthweight 
 
Observers’ and women’s self-reports of newborn gram weight were very highly correlated (r= 0.97). The 
high degree of correlation may partially reflect the standard facility practice of providing each mother 
with a bracelet that listed her newborn’s birthweight, which may have increased the salience of this 
indicator. To account for this, validity analysis was restricted to women who reported their newborn’s 
weight themselves, rather than taking the weight from a card (which occurred in 3 cases). We classified 
newborn birthweight into 3 categories: low birthweight (<2,500 grams), normal birthweight (2,500- 
4,499 grams), and high birthweight >4,500 grams). Most newborns were normal weight (88%), 12% 
were low birthweight, and none were high birthweight.  
 
Women’s self-report of low and normal newborn birthweight was near perfect. Specifically, all women 
who delivered a low birthweight newborn accurately reported their newborn’s weight to be less than 
2,500 grams (100% sensitivity); the indicator also had 99% specificity. Similarly, normal newborn 
birthweight was reported with 99% sensitivity and 100% specificity. Given the lack of variation in the 
data, we were unable to analyze these indicators fully. However, women’s near-perfect reporting 
accuracy indicates that this information was highly memorable. While the high accuracy may be in part 
due to the practice of providing women with a bracelet that listed their newborn’s weight, study 
interviewers also agreed that information related to the baby’s weight seemed to be important to 
women and was easily recalled.  
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Stillbirth delivery 
 
 Given the small number of stillbirth deliveries (n=3 observed, matched data n=2 due to missing data in 
client exit interview), we were unable to analyze the 
validity of an indicator of stillbirth deliveries. While 
results should be interpreted with caution, 
descriptive cross-tabulations (Box 10) indicate that 
both stillbirth deliveries were correctly classified by 
women.  
 
 
NEWBORN OUTCOMES: SUMMARY 
Newborn birthweight was nearly perfectly reported by women, and likely reflected the fact that all 
women were given a bracelet with the newborn’s birthweight listed. Very few newborns were stillborn, 
but the 2 stillborn cases that occurred were accurately reported. 
 
 
Box 10. Cross-tabulation: Stillbirth delivery.  
    Observer Report (Number) 
S
e
lf
-R
e
p
o
rt
 
(N
u
m
b
e
r)
 
 Alive  Stillbirth Total 
Alive  589 0 589 
Stillbirth 0 2 2 
Total 589 2 591 
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Discussion 
Overview: 
48 out of 108 possible indicators had sufficient variation in numbers for validity analysis. Of these, 5 
indicators met both acceptability criteria (AUC>0.6 and 0.75<IF<1.25) (Table 4). 28 of these indicators 
met only one of the acceptability criteria. Few indicators met both study validity criteria, in part because 
many quality of care interventions were either routinely practiced or rarely occurred (see Annex A, Table 
2). As a result, there was often insufficient variation in women’s and observers’ reports for robust 
validity analysis.  
 
Validated Indicators that Met Study Validity Criteria 
Study findings suggest women’s report of indicators 
that ‘became significant for them’ were most likely to 
be validly reported. Salient events included aspects 
of care that had caused pain, such as receiving an 
episiotomy, or were cause for concern, such as 
experiencing hemorrhage or receiving a blood 
transfusion. It is noteworthy, however, that although 
indicators on urine sample screening, experiencing hemorrhage, and receiving blood products met 
study validity criteria, each of these indicators had low sensitivity (50% for urine sample and 
hemorrhage; 36% for blood products). These findings indicate that of women who experienced these 
events, half or more did not report it. Because postpartum hemorrhage is a leading cause of maternal 
death, and blood transfusion and a urine screen for pre-eclampsia/eclampsia are potentially lifesaving 
interventions, the low sensitivity of these indicators would not capture critical information regarding the 
women who experienced these events. If the goal of using these indicators is not to obtain an accurate 
record of true positive and true negative cases, but rather to approximate the prevalence of the 
indicators in the population, the IF of nearly 1 suggests that the indicators may be suitable to estimate 
coverage at an aggregate level. 
Receiving an injection or IV medication at some time during labor, before the birth of the baby (proxy for 
uterotonic for labor induction or augmentation), also met both validity criteria. The high sensitivity (70%) 
of this indicator may reflect the observation that upon admission to the labor /delivery ward it was 
universal practice for women to have an IV line set, which also likely decreased the use of alternative 
drug administration routes. Taken together, these results suggest women may be able to report whether 
TABLE 4.  Indicators that met both validation 
criteria.  
Provider takes a urine sample at or near facility 
admission 
Injection or IV medication received at some time 
during labor, before the birth of the baby 
Episiotomy was performed 
Complication of hemorrhage was experienced  
Blood products were given 
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an injection or IV medication was received, but not on the indication for the intervention (whether the 
medication was received for induction or augmentation of labor).  
 
Indicators on Skilled Birth Attendance 
A key objective of the study was to assess the validity of women’s reports of ‘skilled attendance at 
birth’, i.e., what category of provider assisted with labor and delivery. Skilled birth attendance (i.e., 
doctor/ob-gyn, medical resident, or nurse) was common, with greater than 90% observed prevalence 
regardless of delivery phase or provider role (main provider or additional provider present). Cross-
tabulation results (additional provider indicator) reflect high sensitivity and low specificity of women’s 
self-reports on skilled birth attendance. However, given there were few instances when a skilled 
provider was not present, these results demonstrate that unless women had near perfect specificity in 
reporting, this indicator is likely to be overestimated. 
Of specific relevance to this context was to test women’s accuracy in identifying when the main provider 
belonged to a skilled category. The skilled provider most commonly observed was a medical resident 
(>92% across delivery phases). Of note is that in Mexico, there is little distinction between the skill level 
of a medical resident and other doctor categories (general practitioners, ob-gyn specialists) since they 
would all be classified as skilled providers. We therefore assessed the validity of a composite doctor/ob-
gyn/medical resident indicator. This composite indicator did not meet both validity criteria, irrespective 
of delivery phase or provider role (main provider or additional provider present). Similar to ‘skilled birth 
attendance’, the doctor/ob-gyn/medical resident indicator was marked by high sensitivity and low 
specificity. As with the ‘skilled provider’ indicator, our results are limited by the lack of variation in 
provider type, since the tendency to overreport low-prevalence scenarios was common when specificity 
levels were not high.  
 
The discrepancy in reporting on ‘skilled birth attendance’ and doctor/medical resident indicators may 
also reflect differences in how women and observers identified the provider with the ‘main’ role. 
Observers report identifying the primary provider as the staff member who spent the most time or 
conducted the majority of actions during labor or delivery. It is possible that women instead 
conceptualized the ‘main’ provider as the birth attendant who had the highest rank and was deemed to 
be ‘in charge’ of care. The high number of attendants at each birth (mean: 4 ± 2) and the setting of a 
teaching hospital setting may also have contributed to women’s difficulty in identifying the ‘main’ 
provider. Future qualitative analysis is recommended to explore how women understand key terms in 
birth attendant indicators and women’s understanding of the existence and differences between the 
doctor cadres. 
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While the low prevalence of instances when a skilled doctor was not present limited our ability to 
analyze whether women could distinguish among finer categories of providers, it is important to note 
that 8 birth attendant indicators met the IF criteria alone. This included whether the main provider who 
caught the newborn during delivery was a doctor/ob-gyn or medical resident. Birth attendant indicators 
that met the IF criteria alone may be useful for assessing the population-based coverage of these 
provider types. Given that broad categorizations of provider levels (i.e., whether the provider is skilled or 
some type of doctor) are likely to be more programmatically meaningful than the ability of women to 
delineate between specific provider types, the composite doctor indicator may be of particular use at 
the population level. 
 
Validated Indicators that Met At Least One Study Validity Criteria 
 
In addition to skilled birth attendance, other core indicators have high potential for practical use. We 
define ‘core’ indicators as those included in DHS and MICS surveys, or that reflect essential aspects of 
obstetric and immediate newborn care. Core assessed indicators that met at least one validity criteria 
were: HIV status checked, receiving a uterotonic up to 3 minutes following the birth and whether 3 
essential components of AMTSL were received. Each of these indicators met the IF validation criteria 
alone, suggesting they may produce an acceptable estimate of indicator prevalence at the population 
level. Because these indicators did not meet the AUC criteria, they are not recommended for classifying 
which individual women received a specific intervention. However, at the aggregate level, the tendency 
for underreporting of true cases and overreporting of false cases cancel out to produce an acceptable 
population-based estimate. 
 
Indicators Reported with Difficulty 
 
Other indicators were reported with difficulty and had notably high ‘Don’t Know’ responses by women. 
These include measures of specific medications or injections received, HIV testing, provider hygiene 
(hand sanitization or sterile glove use), aspects of immediate postpartum care (whether baby was 
immediately dried after birth, when the baby was first bathed, whether the baby was given anything else 
to eat or drink in the first hour after birth), and provider health checks for involution (whether the womb 
was becoming firm) in the first health exam post-delivery (see Annex A, Table 3).  
The high ‘Don’t Know’ responses on these indicators reflect study interviewer notes for indicators where 
they had to provide additional clarification to explain questions or terms to women. For example, HIV 
48 
was commonly confused with HPV, and interviewers frequently explained the difference between the 
two distinct sexually transmitted diseases. Interviewers also had to provide lengthy explanations about 
differences between receiving an epidural and other types of injections or IV medications. Interviewers 
commonly noted using body language to demonstrate the place where an epidural relative to other 
injections was administered. Other indicators where interviewers felt they had to provide additional 
clarification related to questions using the term ‘immediate’. While allowing for an initial spontaneous 
response from the woman, the interviewer would then specify that the question referred to an 
‘immediate action’ and sometimes asked the woman to estimate the number of minutes that had 
passed to enable her to respond more accurately to the question.  
Women also had difficulty reporting some aspects of interventions related receiving uterotonics. This 
result is supported by women‘s high ‘Don’t Know’ responses on indicators of uterotonic administration 
for PPH—whether oxytocin was received following delivery or whether anyone gave medication 
intravenously through a tube in the first few minutes after delivery (37% and 7%, respectively). The fact 
that some women accurately reported receiving medication by IV line following delivery, but did not 
report receiving oxytocin, despite being observed to receive oxytocin via IV line in this time period (Box 
5D), could suggest that women recall having an IV line set because it was standard practice, but did not 
have specific knowledge of uterotonics received. Taken together, these results suggest that women can 
report some aspects of care routinely received, but may have difficulty with specific details (timing, 
name, route of administration) of medications received. This is likely because intervention procedures, 
in general, and specifically those regarding the use of medications were rarely explained to women, as 
noted by observers. Indicators regarding receiving uterotonics should be used with consideration of 
whether the purpose is to classify individual women who received the intervention, or to obtain an 
acceptable coverage estimate of the intervention at the population level. IF results suggest that one 
indicator— whether a uterotonic was received up to 3 minutes following delivery—may produce valid 
results only at the aggregate level. 
In addition to data collector notes, quantitative findings also highlight the importance of indicator 
wording on women’s reporting. For example, a two-item indicator about whether the newborn was 
placed skin-to-skin on the mother’s chest immediately after delivery greatly reduced women’s 
overestimation of the practice compared to a one-item indicator. Quantitative findings and observer 
notes also suggest that women have difficulty reporting details related to the specific timing, routes, 
and names of medications received. These results suggest that women’s conceptualization of key terms 
used in survey items (e.g., understanding of directly ‘on skin’ as opposed to wrapped in a towel and 
placed on the skin, and terms such as ‘immediate’ or ‘within a few minutes’) should be further explored 
to better refine indicators.  
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Indicators to be Further Researched 
 
Because institutional delivery is a widely used proxy of whether women have access to comprehensive 
services such as emergency obstetric care and lifesaving commodities (e.g., uterotonics, magnesium 
sulfate, antibiotics), it is of interest whether women can accurately report on the type of facility where 
they delivered. The present study was not designed to assess whether women can accurately report on 
this indicator. However, cross-tabulation results show that a high proportion of women (85%) who 
responded to this indicator correctly classified the type of facility as a public/ government hospital. 
Additionally, of women not able to classify the study facility as private or public, the majority (83%) 
correctly named the facility and 4% specified details including whether the facility was a hospital and 
part of the public or governmental sector. These results suggest that both aspects of question 
methodology, also used in DHS and MICS surveys, are important. These findings should be explored 
further in a study that includes multiple facility types (private and public sector).  
 
An additional indicator, which we were unable to assess because of near-perfect correlation between 
observers’ and women’s responses, but which suggests the potential for valid reporting, was newborn 
birthweight. Specifically, women reported normal (2,500-4,499 grams) and low (<2,500 grams) 
newborn birthweight with near 100% accuracy. While the hospital practice of giving women bracelets 
listing the newborn birthweight, may have increased the salience of this indicator, analysis was 
restricted to women who recalled the weight from memory. Study interviewers also anecdotally 
corroborated the seeming importance of newborn birthweight, as women readily recalled the number. 
Occasionally women were able to recall only the amount in kilos and confirmed the grams after looking 
at their bracelet. Interviewers also noted that although not questioned on it, women spontaneously 
reported on the time of birth as another memorable event. 
 
Another general trend observed was that some universal practices, particularly related to the client’s 
initial assessment or the mother’s post-partum health checks, were reported with high sensitivity by 
women. Although the high prevalence of these indicators limited robust analysis, it is noteworthy that in 
the few cases where women did not receive these preventative interventions, a high proportion of 
women falsely reported receiving them, suggesting low specificity. Because there were too few 
instances of women not receiving this type of care to robustly assess these indicators, this trend should 
be further explored. These findings may suggest that women in the Mexico setting may be positively 
biased towards reporting on aspects of preventative care received in the initial assessment and on 
health checks for the mother in the post-partum maternal period. It may also reflect the fact that, with 
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regard to low- prevalence scenarios, lack of high specificity in women’s self-report may led to 
overestimation of the indicator.  
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Annexes 
 
Annex A.  
 
TABLE 1. Full List of Indicators Assessed and Measured Coverage,a,b Mexico. 
 
Indicator  Self-Report Prevalence 
(Matched data) 
True Prevalence 
(Matched data) 
At least 5 
counts/cell? 
Initial Client Assessment 
Type of facility where gave birth- public hospital  85.20 100.00 N 
HIV status checked  54.13 69.77 Y 
Offered HIV test  14.31 1.79 N 
Received HIV test  16.32 1.17 N 
Provider washes hands with soap and water or uses 
antiseptic before any initial examination 
 
95.85 1.97 N 
Takes blood pressure  98.80 97.77 N 
Takes urine sample  24.30 25.17 Y 
Checks fetal heart rate with fetoscope/ ultrasound  97.78 97.78 N 
Wears high-level disinfected or sterile gloves for vaginal 
examination 
 
100.00 99.65 N 
Provider Respectful Care 
Encourages/assists woman to ambulate during labor  8.28 22.24 Y 
Woman allowed to drink liquids/eat  2.88 0.51 N 
Woman allowed to have a support person present 
during labor and delivery  
 
0.35 0.00 N 
Encourages/assists woman to assume different 
positions in labor 
 
3.90 67.63 N 
A support person is present at some point during labor  0.17 0.85 N 
A support person is present at birth  0.17 1.02 N 
First Stage of Labor 
Induces by uterotonic (IV line, IM injection, or tablet) d 12.88 11.63 Y 
(Of women whose labor was induced) Uterotonic route 
for induction of labor by IV line d   27.69 100.00 
N 
Augments labor with uterotonic (by IV line, IM 
injection, or tablet) d 41.95 75.21 
Y 
(Of women whose labor was augmented) 
Augmentation of labor by IV line d 57.25 100.00 
N 
Receives injection during labor (to induce or augment 
labor) d 49.79 76.05 
Y 
Injection or IV medication received at some time during 
labor, before birth of baby (general) 
63.57 76.01 
Y 
Membranes ruptured (to induce or augment labor) d 26.97 57.02 Y 
 
   
 
2 
Indicator Self-Report Prevalence 
(Matched data) 
True Prevalence 
(Matched data) 
At least 5 
counts/cell? 
Skilled Birth Attendance- Main Provider 
Skilled main provider labor c, d 95.69 96.72 N 
Main provider labor- doctor or medical resident d 81.90 96.21 N 
Main provider labor- doctor (any)  76.72 1.72 N 
Main provider labor- medical resident  5.17 94.48 N 
Main provider labor- medical intern  3.62 3.28 N 
Main provider labor- nurse  13.79 0.52 N 
Main provider labor- nursing student /intern  0.69 0.00 N 
Skilled main provider delivery c, d 97.77 92.81 N 
Main provider delivery- doctor or medical resident† 95.66 92.36 N 
Main provider delivery- doctor (any) 92.81 2.40 N 
Main provider delivery- medical resident 2.91 90.07 N 
Main provider delivery- medical student/ intern 2.23 7.19 N 
Main provider delivery- nurse 2.05 0.34 N 
Main provider delivery- nursing student /intern 0.00 0.00 N 
Skilled main provider caught baby c, d 96.98 92.18 N 
Main provider caught baby- doctor or medical resident d 89.70 91.12 Y 
Main provider caught baby- doctor (any) 85.79 10.12 N 
Main provider caught baby- medical resident 3.91 80.99 N 
Main provider caught baby- medical student/ intern 2.31 7.82 N 
Main provider caught baby- nurse 7.28 1.07 N 
Main provider caught baby- nursing student /intern 0.17 0.00 N 
Skilled Birth Attendant- Other Providers Present 
Skilled other provider labor  c, d 92.05 96.95 N 
Other provider labor- doctor or medical resident 70.39 84.60 Y 
Other provider labor- doctor (any) 65.65 20.14 Y 
Other provider labor- medical resident 11.76 77.65 Y 
Other provider labor- medical student/intern 23.01 65.31 Y 
Other provider labor- nurse 62.61 80.88 Y 
Other provider labor- nursing student/intern 7.45 17.77 Y 
Skilled other provider delivery  c, d 97.14 97.98 N 
Other provider delivery- doctor or medical resident 82.32 88.22 Y 
Other provider delivery- doctor (any) 79.46 24.58 Y 
      Other provider delivery- medical resident 13.79 81.56 Y 
      Other provider delivery- medical student/intern 26.26 39.06 Y 
      Other provider delivery- nurse 81.14 81.99 Y 
      Other provider delivery- nursing student/intern 6.90 9.26 Y 
      Other provider delivery- pediatrician 39.40 6.84 Y 
      Other provider delivery- anesthesiologist 9.76 4.55 Y 
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Indicator Self-Report Prevalence 
(Matched data) 
True Prevalence 
(Matched data) 
At least 5 
counts/cell? 
Number of Providers 
Four or more providers assisted with birth d 94.44 66.16 Y 
More than six providers assisted with birth 37.54 13.64 Y 
More than seven providers assisted with the birth 23.23 5.72 Y 
Second & Third Stage of Labor 
Episiotomy performed 78.10 67.76 Y 
Position of mother at birth- on back 93.30 99.66 N 
Did health provider wear gloves during delivery of baby 99.82 99.29 N 
Uterotonic administered within few minutes of delivery (IV 
line, IM injection, or tablets) 60.88 99.33 
N 
Uterotonic received 1-3 minutes after delivery  60.69 63.97 N 
Uterotonic received after delivery of placenta 94.10 19.97 Y 
Method of uterotonic administration- IV line 62.20 100.00 N 
Oxytocin given following delivery 50.00 99.16 N 
Applies controlled cord traction 93.83 96.91 N 
Performs uterine massage after birth 82.37 83.07 Y 
Palpates uterus 15 minutes after delivery of placenta 79.66 82.41 Y 
3 AMTSL elements: prophylactic uterotonic, controlled cord 
traction, uterine massage post-placenta d 
75.77 81.18 Y 
Immediate Newborn Care (babies breathing at birth) 
Baby immediately dried with towel/cloth 99.27 93.58 N 
Baby given to mother immediately after birth 59.83 10.34 Y 
Baby placed immediately skin-to-skin on mother's abdomen 11.36 0.17 N 
Baby immediately skin-to-skin on mother (2 item) d,e  1.05 0.17 N 
Babies not on skin wrapped with towel 99.12 98.77 N 
Breastfeeding within 1st hour of birth 64.81 34.74 Y 
Something other than breastmilk given to baby within 1st 
hour of delivery 57.76 21.69 
Y 
Baby bathed within the first hour after birth d 0.68 2.72 N 
Baby weighed 98.81 NA N 
Low birth-weight baby (<2,500 g) d 12.05 11.21 N 
High birth-weight baby (>=4,500 g) d 0 0 N 
3 elements of newborn care (newborn immediately dried + 
placed naked on skin + breastfed within 1st hr) d 9.66 0.00 
N 
3 elements of newborn care (newborn immediately dried +  
placed naked on skin (2 item) e + breastfed within 1st hr) d 0.74 0.00 
N 
Immediate Postnatal Care 
Provider did at least one post-delivery health check d 100.00 99.30 N 
In first post-delivery exam, checks for bleeding 87.46 80.51 Y 
In first post-delivery exam, examines perineum 90.10 75.09 Y 
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Indicator Self-Report Prevalence 
(Matched data) 
True Prevalence 
(Matched data) 
At least 5 
counts/cell? 
In first post-delivery exam, takes temperature 93.34 66.89 Y 
In first post-delivery exam, takes blood pressure 93.38 95.59 Y 
In first post-delivery exam, checks for involution 83.45 81.65 Y 
Maternal and Newborn Outcomes 
Cesarean section (C/S) performed 9.68 9.98 N 
Decision for C/S taken after labor started 84.62 94.87 N 
C/S performed after labor started 84.62 94.87 N 
Provider decided C/S would be done 97.30 100.00 N 
Reason for C/S- prolonged/ obstructed labor 21.62 29.73 Y 
Complications (any) 38.15 13.61 Y 
Eclampsia 21.38 2.36 Y 
Hemorrhage 8.43 8.09 Y 
Prolonged labor (>12 hours) 7.39 2.18 N 
Prolonged/obstructed labor 10.76 3.03 N 
None 61.85 86.39 Y 
Blood products given 2.41 2.41 Y 
Woman asked for pain relief medication while at facility  26.26 44.70 Y 
Woman received pain relief medication 87.44 79.35 Y 
Stillborn delivery d 0.34 0.34 N 
a Text in blue notes indicators where there was not sufficient cell counts for robust analysis (n<5 per cell). 
b Excludes ‘Don’t Know’ responses. 
c Skilled provider is doctor (ob-gyn), nurse/midwife or medical resident 
d Indicator constructed in analysis to dichotomize women’s responses to related question. 
e Indicator constructed from two skin-to-skin items: (1) baby placed against mother’s chest after delivery and (2) baby was naked against the     
    mother’s chest. 
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Annex A.  
 
TABLE 2. Near Universal and Rare Indicators, Unmatched Data 
 
Indicator  
True Prevalence 
 
Near Universal practices (>95%) 
Provider takes woman’s blood pressure 99.8 
Fetal heart rate checked with fetoscope/Doppler ultrasound 97.8 
Provider wore high-level disinfected or sterile gloves for vaginal examination 99.7 
(Of those with induced labor), route for induction of labor by IV line 100.0 
(Of those with augmented labor), route for augmentation of labor by IV line 100.0 
Skilled main provider during labor (doctor, medical resident, or nurse) 96.7 
    Skilled additional  provider during labor (doctor, medical resident, or nurse)            97.0 
    Skilled  additional  provider at delivery (doctor, medical resident or nurse) 97.1 
    Main provider during labor- medical resident  
Health provider wore gloves during delivery  99.3 
Position of mother at birth – on back 99.7 
Prophylactic uterotonic administered 99.3 
Method of prophylactic uterotonic- IV line 100.0 
Oxytocin given following delivery 96.2 
Controlled cord traction 96.9 
Newborn not placed skin-to-skin, wrapped in dry towel 98.8 
Provider did at least one post-delivery health check 99.3 
Of those who received cesarean section, provider made decision  100.0 
Rare practices (<5%) 
Offered HIV test  1.8 
Woman received HIV test 1.2 
Provider washes hands with soap and water or uses antiseptic before each  examination  2.0 
Takes urine sample 1.4 
Woman is allowed to drink liquids or eat during labor 0.5 
Woman is allowed to have support person present during labor and delivery 0.0 
A support person is present at some point during labor 0.9 
A support person is present at birth  1.0 
Main provider labor – nurse 0.5 
Main provider labor – nursing student/ intern 0.0 
Newborns placed immediately skin-to-skin on mother’s abdomen 0.2 
Newborns placed directly on mother’s skin are covered with dry towel on mother’s abdomen 0.0 
Baby bathed within the first hour after birth 2.7 
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TABLE 3. Indicators with High ‘Don’t Know’ Responses, Unmatched data 
 
 
 
  
Indicator   
% “Don’t 
Know” 
Woman’s Self-Report (>5% DK) 
Did anyone give you a medication called ‘oxytocin’ to make your womb contract or become firm?  37.3 
Did anyone give you medication or an injection called ‘oxytocin’ before you delivered the placenta?  35.8 
While you were at the health facility for the birth of your baby, did anyone test you for HIV?  23.2 
Did you or anyone else give anything to the baby to eat or drink within the first hour after delivery?  21.0 
Did the health provider(s) wash their hands with soap and water or use antiseptic before examining 
you? 
 18.9 
In the first few minutes after the delivery of your baby, did anyone give you medication intravenously 
through a tube in your arm? 
 6.9 
Was your baby dried off with a towel or cloth immediately after birth, within a few minutes of delivery?  6.4 
About how long after birth was your baby bathed for the first time?  5.9 
In your first physical examination/check after delivery, did a health provider check your belly to see 
whether your womb was becoming firm?  
 5.7 
Did the health providers wear rubber gloves to handle the placenta?  5.4 
Observers’ Self-Report (>2% DK) 
Was anything besides breast milk given to the baby to drink within the first hour after birth?  5.6 
Was an HIV test done?  4.1 
Provider performs artificial rupture of the membranes  4.1 
Provider checks woman’s HIV status (checks chart or asks woman)  3.3 
Provider washed his/her hands with soap and water or used antiseptic before each 
examination of the woman 
 3.3 
Provider ties or clamps cord when pulsations stop or by 2-3 minutes after birth (not 
immediately after birth). 
 3.0 
Did the woman ask for any pain relief medication during labor, delivery, or immediately 
postpartum? 
 2.8 
Provider takes urine sample to check for presence of proteins  2.6 
Baby bathed within the first hour after birth.  2.5 
What was the indication for the cesarean operation?  2.4 
Provider encourages woman to have a support person present throughout labor and birth  2.1 
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Annex B.  
TABLE 1. Validation Results for ALL Indicators With at Least 5 Counts per Cell, Matched Data*, Mexico. 
Indicator 
N 
 
Matched 
data 
Reported 
Prev (%) 
 
Matched 
data 
True Prev 
(%) 
 
Matched 
data 
Sensitivity of 
Self- Report 
Specificity of 
Self-Report 
 
Population 
Survey 
Estimate 
AUC 
 
(>0.60) 
IF 
 
(0.75
to 
1.25) 
Recommend? 
(Y/N) 
List Criteria 
Initial Client Assessment  
HIV status checked 569 54.13 69.77 54.91 47.67 54.13 0.5129 0.78 IF 
Takes urine sample 572 24.30 25.17 50.00 84.35 24.30 0.6717 0.97 Yes 
Provider Respectful Care 
Encourages/assists woman to ambulate during labor 580 8.28 22.24 7.75 91.57 8.28 0.4966 0.37  
First Stage of Labor 
Induces labor with uterotonic  559 12.88 11.63 27.69 89.07 12.88 0.5838 1.11 IF 
Augments labor with uterotonic 472 41.95 75.21 49.58 81.20 41.95 0.6539 0.56 AUC 
Receives injection for induction or augmentation of labor 476 49.79 76.05 59.12 79.82 49.79 0.6947 0.65 AUC 
Injection or IV medication received at some time during labor, 
before birth of baby (general) 
571 63.57 76.01 70.05 56.93 63.58 0.6349 0.84 Yes 
Membranes ruptured (labor induction or augmentation) 356 26.97 57.02 38.42 88.24 26.96 0.6333 0.47 AUC 
Skilled Birth Attendance 
Main provider   
Main provider labor- doctor or medical resident 580 81.90 96.21 82.26 27.27 81.90 0.5477 0.85 IF 
Main provider delivery (who caught baby)– doctor or 
medical resident 
563 89.70 91.12 90.06 14.00 89.70 0.5203 0.98 IF 
Other providers present          
Other provider during labor was skilled a 591 92.05 96.95 92.15 11.11 92.05 0.5163 0.95 IF 
Other provider during labor – doctor or medical resident 591 70.39 84.60 71.80 37.36 70.39 0.5458 0.83 IF 
Other provider during labor – doctor (any) 591 65.65 20.14 72.27 36.02 65.65 0.5414 3.26  
Other provider during labor – medical resident 595 11.76 77.65 12.34 90.23 11.77 0.5128 0.15  
Other provider during labor – medical student /intern 591 23.01 65.31 25.65 81.95 23.01 0.5380 0.35  
Other provider during labor – nurse 591 62.61 80.88 64.02 43.36 62.61 0.5369 0.77 IF 
Other provider during labor – nursing student/ intern 591 7.45 17.77 8.57 92.80 7.44 0.5068 0.42  
Other providers during delivery - doctor or medical resident 594 82.32 88.22 82.82 21.43 82.32 0.5213 0.93          IF 
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Indicator 
N 
 
Matched 
data 
Reported 
Prev (%) 
 
Matched 
data 
True Prev 
(%) 
 
Matched 
data 
Sensitivity of 
Self- Report 
Specificity of 
Self-Report 
 
Population 
Survey 
Estimate 
AUC 
 
(>0.60) 
IF 
 
(0.75
to 
1.25) 
Recommend? 
(Y/N) 
List Criteria 
Other providers during delivery - doctor (any) 594 79.46 24.58 81.51 21.21 79.46 0.5136 3.23  
Other providers during delivery - anesthesiologist 594 9.76 4.55 33.33 91.36 9.76 0.6235 2.15 AUC 
Other providers during delivery - pediatrician 599 39.40 6.84 41.46 60.75 39.40 0.5111 5.76  
Other providers during delivery – medical resident 602 13.79 81.56 13.65 85.59 13.79 0.4962 0.17  
Other providers during delivery – medical student/ intern 594 26.26 39.06 31.03 76.80 26.26 0.5392 0.67  
Other providers during delivery – nurse 594 81.14 81.99 82.96 27.10 81.15 0.5503 0.99 IF 
Other providers during delivery – nursing student/ intern 594 6.90 9.26 5.45 92.95 6.90 0.492 0.75 IF 
Second and Third Stage Labor          
Episiotomy performed 580 78.10 67.76 97.71 63.10 78.10 0.8041 1.15 Yes 
Uerotonic received 1-3 minutes after delivery 580 60.69 63.97 61.46 40.67 60.69 0.5106 0.95 IF 
Uterotonic received following delivery of placenta 576 94.10 19.97 95.65 6.29 94.10 0.5097 4.71  
Palpates uterus 15 minutes after delivery of placenta 580 79.66 82.41 79.50 19.61 79.66 0.4955 0.97 IF 
3 AMTSL elements: prophylactic uterotonic + controlled cord 
traction + uterine massage post-delivery of placenta 
549 75.77 81.18 75.72 24.00 75.7 0.4986 0.93 IF 
4+ providers assisted with the birth 573 82.37 83.07 82.14 16.49 82.37 0.4932 0.99 IF 
7+ providers assisted with the birth 594 37.54 13.64 59.26 65.89 37.54 0.6257 2.75 AUC 
8+ providers assisted with the birth 594 23.23 5.72 50.00 78.39 23.24 0.6420 4.06 AUC 
Immediate Newborn Care  
Baby given to mother immediately after birth 580 59.83 10.34 63.33 40.58 59.82 0.5196 5.78  
Breastfeeding within 1st hour of birth 449 64.81 34.74 81.41 44.03 64.81 0.6272 1.87 AUC 
Something other than breastmilk given to baby within 1st hour 
of birth 
438 57.76 21.69 71.58 46.06 57.77 0.5882 2.66  
Immediate Postnatal Care  
First post-delivery exam, provider ask/checks for bleeding 590 87.46 80.51 87.37 12.17 87.46 0.4977 1.09 IF 
First post-delivery exam, provider examines perineum 586 90.10 75.09 90.23 10.27 90.11 0.5025 1.20 IF 
First post-delivery exam,  provider takes temperature 586 93.34 66.89 94.39 8.76 93.35 0.5158 1.40  
First post-delivery exam,  provider takes blood pressure 589 93.38 95.59 93.25 3.85 93.38 0.4855 0.98 IF 
First post-delivery exam, provider checks for involution 556 83.45 81.65 84.58 21.57 83.45 0.5308 1.02 IF 
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Indicator 
N 
 
Matched 
data 
Reported 
Prev (%) 
 
Matched 
data 
True Prev 
(%) 
 
Matched 
data 
Sensitivity of 
Self- Report 
Specificity of 
Self-Report 
 
Population 
Survey 
Estimate 
AUC 
 
(>0.60) 
IF 
 
(0.75
to 
1.25) 
Recommend? 
(Y/N) 
List Criteria 
Maternal Outcomes          
Complication (yes to any) 595 38.15 13.61 60.49 65.37 38.15 0.6293 2.80 AUC 
       Eclampsia 594 21.38 2.36 57.14 79.48 21.38 0.6831  9.07 AUC 
Hemorrhage 593 8.43 8.09 50.00 95.23 8.43 0.7261 1.04 Yes 
None 595 61.85 86.39 65.56 61.73 61.84 0.6365 0.72 AUC 
Blood products given 582 2.41 2.41 35.71 98.42 2.40 0.6706 1.00 Yes 
Woman asked for pain relief medication at some time  575 26.26 44.70 32.68 78.93 26.26 0.5581 0.59  
Woman received pain relief medication  581 87.44 79.35 89.37 20.00 87.43 0.5469 1.10 IF 
* Excluding ‘Don’t Know’ responses. 
a Skilled provider includes doctor (ob-gyn), medical resident or nurse/midwife. 
 
 
 
 
